Pain in limb

M13_LIMBPAIN

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M79.6 Cause of death: ICD-10 — M79.6 2 out of 7 registries used, show all original rules.	47232
4. Check minimum number of events None	47232
5. Include endpoints None	47232
6. Filter based on genotype QC (FinnGen only)	47232

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M79
Name in latin: Melalgia

NAME	M13_LIMBPAIN
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M796
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M796
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pain in limb based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	328528	196590	130443
Only index persons	306752	186403	120349
Unadjusted period prevalence (%)
Whole population	4.82	5.63	3.64
Only index persons	5.97	6.85	4.59
Median age at first event (years)
Whole population	54.52	55.37	53.37
Only index persons	54.92	55.49	54.03

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	47232	30384	16848
Unadjusted period prevalence (%)	9.31	10.36	7.43
Median age at first event (years)	57.36	54.74	62.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
37735: Matched controls
288960

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.6

323.0

3385

10538

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.9

323.0

811

639

M01AX05

ATC

glucosamine; oral

2.3

323.0

5510

20301

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

5.3

323.0

1478

2224

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

323.0

14836

59579

G54.0

ICD-10 Finland

Brachial plexus disorders

5.8

323.0

1061

1443

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

10.4

323.0

986

742

ZXD05

NOMESCO Finland

Urgent procedure

1.7

323.0

10881

56857

WX320

NOMESCO Finland

Spinalanesthesy

2.1

323.0

7697

31585

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

323.0

3284

10547

L17

ICPC

Foot/toe symptom/complaint

2.8

323.0

10373

34234

Z3231

NOMESCO Finland

Registered nurse

1.9

323.0

9907

45226

UJF32

NOMESCO Finland

Coloscopy

2.1

323.0

8645

35185

J01MA02

ATC

ciprofloxacin; systemic

1.8

323.0

12925

65691

K30

ICD-10 Finland

Functional dyspepsia

2.3

323.0

3420

11879

A02BA02

ATC

ranitidine; systemic

2.0

323.0

6206

25453

J01DB01

ATC

cefalexin; oral

2.4

323.0

30953

188666

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.7

323.0

18481

76612

M01AH01

ATC

celecoxib; oral (coxibs)

2.5

323.0

6121

20575

L08

ICPC

Shoulder symptom/complaint

2.8

323.0

6630

20532

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

323.0

9656

43127

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.9

323.0

4173

12074

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.9

323.0

3004

8320

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

323.0

10966

42647

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.8

323.0

2954

8421

K02.1

ICD-10 Finland

Caries of dentine

1.6

323.0

20075

121389

R07.4

ICD-10 Finland

Chest pain, unspecified

2.8

323.0

10471

35193

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

5.1

323.0

1773

2750

M54.5

ICD-10 Finland

Low back pain

2.9

323.0

14136

49318

S18

ICPC

Laceration/cut

2.2

323.0

15082

67094

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

323.0

8839

33266

L03

ICPC

Low back symptom/complaint

2.5

323.0

9344

33656

L15

ICPC

Knee symptom/complaint

2.6

323.0

7741

26247

Z2221

NOMESCO Finland

Medical doctor

1.7

323.0

9699

49564

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

323.0

6906

31686

S06.0

ICD-10 Finland

Concussion

2.3

323.0

3684

13042

ZXE00

NOMESCO Finland

One hour or less

1.8

323.0

14376

72776

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

17.2

323.0

2046

961

M54.4

ICD-10 Finland

Lumbago with sciatica

3.6

323.0

7346

18363

J01FA10

ATC

azithromycin; systemic

1.6

323.0

20394

122516

A46

ICD-10 Finland

Erysipelas

2.4

323.0

4817

16394

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

323.0

12864

60311

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

323.0

7501

30223

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.0

323.0

2374

6369

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

323.0

16319

86807

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

323.0

6468

23145

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

323.0

17403

94771

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.7

323.0

4019

12254

AA1AD

NOMESCO Finland

CT of head and brain

2.3

323.0

8172

31099

L14

ICPC

Leg/thigh symptom/complaint

3.4

323.0

2941

6959

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

323.0

17455

95032

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

323.0

6211

24614

M02AA10

ATC

ketoprofen; topical

2.1

323.0

4959

19130

N06AX11

ATC

mirtazapine; oral

2.0

323.0

11415

50853

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.6

323.0

8770

17708

M77.4

ICD-10 Finland

Metatarsalgia

4.2

323.0

1927

3635

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.3

323.0

2326

4380

J01AA02

ATC

doxycycline; systemic

2.0

323.0

27864

167390

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.3

323.0

2419

4487

W19

ICD-10 Finland

Unspecified fall

2.4

323.0

3229

10851

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

323.0

12036

63752

R06.0

ICD-10 Finland

Dyspnoea

2.6

323.0

9416

32828

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

323.0

4942

19041

R05

ICPC

Cough

2.0

323.0

7712

33603

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

323.0

13657

66904

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

323.0

5359

21136

L28

ICPC

Limited function/disability (L)

3.0

323.0

5643

16117

ZXA05

NOMESCO Finland

Left side

2.2

323.0

8597

33564

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

323.0

10656

40420

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.4

323.0

4479

10925

ZXA00

NOMESCO Finland

Right side

2.3

323.0

9376

35795

M79.6

ICD-10 Finland

Pain in limb

16384.0

323.0

37726

38343

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

323.0

4478

17263

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.2

323.0

2386

5890

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

323.0

7258

29886

ACC51

NOMESCO Finland

Release of median nerve

3.1

323.0

2386

6094

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.3

323.0

1338

2439

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

323.0

19845

110938

R20.2

ICD-10 Finland

Paraesthesia of skin

3.1

323.0

2667

6907

J01FF01

ATC

clindamycin; systemic

2.1

323.0

9950

42352

M70.6

ICD-10 Finland

Trochanteric bursitis

4.3

323.0

4335

8436

M01AX17

ATC

nimesulide; oral

2.2

323.0

7796

30994

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

323.0

18385

108997

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.6

323.0

6287

20948

M01AE02

ATC

naproxen; oral, rectal

1.9

323.0

20787

112780

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

323.0

6310

26909

R53

ICD-10 Finland

Malaise and fatigue

2.2

323.0

7556

29473

L13

ICPC

Hip symptom/complaint

2.9

323.0

5383

15710

L16

ICPC

Ankle symptom/complaint

2.7

323.0

3790

11626

C03CA01

ATC

furosemide; systemic

2.1

323.0

8770

35948

M48.0

ICD-10 Finland

Spinal stenosis

3.9

323.0

4394

9554

R4110

NOMESCO Finland

Physiotherapy

2.2

323.0

9756

39985

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

323.0

19702

120149

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.8

323.0

3869

8357

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

6.7

323.0

7135

9657

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.8

323.0

1209

1634

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.1

323.0

2407

3825

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

323.0

4268

15697

Z71.8

ICD-10 Finland

Other specified counselling

1.9

323.0

8739

39236

Z3226

NOMESCO Finland

Physiotherapist

2.4

323.0

7020

25307

N02AA05

ATC

oxycodone; systemic

2.8

323.0

5253

15677

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

323.0

7496

24927

R42

ICD-10 Finland

Dizziness and giddiness

2.4

323.0

7527

27403

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.9

323.0

7151

21236

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

323.0

15739

69207

M54.1

ICD-10 Finland

Radiculopathy

4.3

323.0

1506

2761

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

323.0

3195

8947

M13.9

ICD-10 Finland

Arthritis, unspecified

2.9

323.0

2519

6964

N06AX21

ATC

duloxetine; oral

3.9

323.0

4859

10634

A28

ICPC

Limited function/disability NOS

2.3

323.0

4314

15323

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

323.0

9552

34699

A01

ICPC

Pain general/multiple sites

3.7

323.0

3152

6933

R02

ICPC

Shortness of breath/dyspnoea

2.5

323.0

4165

13696

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

323.0

6657

23696

A02BC03

ATC

lansoprazole; oral

2.1

323.0

9981

41936

H02AB06

ATC

prednisolone; systemic

2.2

323.0

17378

81022

N02BE01

ATC

paracetamol; systemic, rectal

3.7

323.0

33239

192084

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.6

323.0

2418

5343

M01AH02

ATC

rofecoxib; oral

2.5

323.0

4111

13321

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

323.0

7986

32329

N06AB04

ATC

citalopram; systemic

1.8

323.0

7095

32960

M02AA07

ATC

piroxicam; topical

2.1

323.0

12314

53378

R60.0

ICD-10 Finland

Localized oedema

3.4

323.0

4392

10866

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

323.0

25596

156944

WX002

NOMESCO Finland

Sedation and analgesia

2.2

323.0

6859

26081

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.2

323.0

5897

15681

M25.5

ICD-10 Finland

Pain in joint

3.3

323.0

12639

38318

M54.2

ICD-10 Finland

Cervicalgia

3.3

323.0

2650

6492

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.1

323.0

4522

12224

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.3

323.0

3314

6276

N05AH04

ATC

quetiapine; oral

1.9

323.0

5926

25616

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

323.0

7843

37440

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

323.0

13198

61026

R07.3

ICD-10 Finland

Other chest pain

2.8

323.0

3342

9680

N02AX02

ATC

tramadol; systemic, rectal

3.3

323.0

18093

62966

N05CF01

ATC

zopiclone; oral

1.9

323.0

10471

49228

N03AX16

ATC

pregabalin; oral

4.2

323.0

11357

26606

X58

ICD-10 Finland

Exposure to other specified factors

2.4

323.0

5238

18116

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.8

323.0

4779

8517

NBG10

NOMESCO Finland

Acromioplastia

16.9

323.0

647

297

L01

ICPC

Neck symptom/complaint

2.4

323.0

4864

16653

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

4.0

323.0

2712

5521

SPAT1260

SPAT

Consultation of another employee

1.9

323.0

5852

25462

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

6.0

323.0

1041

1367

L02

ICPC

Back symptom/complaint

2.4

323.0

3157

10512

R4120

NOMESCO Finland

Occupational therapy

3.0

323.0

2290

6105

WX110

NOMESCO Finland

Local anesthesy

1.9

323.0

25491

151504

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

323.0

3208

10690

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

323.0

5674

21690

M54

ICD-10 Finland

Dorsalgia

2.2

323.0

3873

14211

M03BX02

ATC

tizanidine; oral

2.2

323.0

23272

121892

J01DA01

ATC

[U] cefalexin; systemic

1.7

323.0

22254

130712

M01AH05

ATC

etoricoxib; oral

2.6

323.0

22647

106842

R03AC02

ATC

salbutamol; inhalant

2.0

323.0

19530

101138

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.6

323.0

3292

10331

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.9

323.0

1718

3523

N05BA01

ATC

diazepam; systemic, rectal

2.1

323.0

4406

17202

B01AA03

ATC

warfarin; systemic

2.0

323.0

6049

24624

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

323.0

8240

33393

C07AB07

ATC

bisoprolol; oral

1.9

323.0

14838

74454

G47.3

ICD-10 Finland

Sleep apnoea

2.0

323.0

7035

30218

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.8

323.0

3567

7735

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.7

323.0

3135

9273

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.9

323.0

2380

6455

SPAT1263

SPAT

Sampling

1.7

323.0

14678

79119

R52.9

ICD-10 Finland

Pain, unspecified

3.6

323.0

3587

8223

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

11.4

323.0

2413

1716

A02BC01

ATC

omeprazole; systemic

2.0

323.0

9451

41074

J01FA09

ATC

clarithromycin; systemic

1.7

323.0

10511

54758

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

323.0

9977

44376

B01AB05

ATC

enoxaparin; parenteral

2.4

323.0

11355

43882

M01AC06

ATC

meloxicam; systemic, rectal

2.1

323.0

12596

54815

C08CA01

ATC

amlodipine; oral

1.7

323.0

10023

51278

R05

ICD-10 Finland

Cough

1.9

323.0

6252

26780

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

323.0

4192

12000

M79.1

ICD-10 Finland

Myalgia

3.8

323.0

5285

11885

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

55.8

323.0

812

114

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

323.0

6183

24408

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.5

323.0

3714

11905

L86

ICPC

Back syndrome with radiating pain

3.4

323.0

2016

4711

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

4.5

323.0

1317

2301

SPAT1153

SPAT

Removal of sutures

1.9

323.0

10360

47241

M77.1

ICD-10 Finland

Lateral epicondylitis

3.3

323.0

2524

6082

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.9

323.0

3219

8871

J02AC01

ATC

fluconazole; systemic

1.7

323.0

13680

72153

M01AB05

ATC

diclofenac; systemic, rectal

2.2

323.0

24635

133169

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.0

323.0

5351

9153

SPAT1301

SPAT

No procedures

1.7

323.0

10392

52549

P01AB01

ATC

metronidazole; oral, rectal

1.9

323.0

14073

69764

R03DC03

ATC

montelukast; oral

2.0

323.0

5371

22331

M67.4

ICD-10 Finland

Ganglion

5.0

323.0

1788

2855

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.2

323.0

2512

6259

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

323.0

9916

44188

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

10.9

323.0

788

564

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

323.0

18221

103267

C10AA05

ATC

atorvastatin; oral

1.7

323.0

10708

55120

NF1AA

NOMESCO Finland

Hip X-ray examination

3.5

323.0

3023

7043

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.0

323.0

3608

9719

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

323.0

5951

19348

SPAT1254

SPAT

Administration of medicine

2.0

323.0

4916

20012

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

323.0

14675

75172

M79.0

ICD-10 Finland

Rheumatism, unspecified

31.7

323.0

1365

341

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.5

323.0

2968

9610

J01CA04

ATC

amoxicillin; systemic

1.7

323.0

29257

192234

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

323.0

10378

50007

N05BA04

ATC

oxazepam; oral

1.9

323.0

8444

38886

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

28.5

323.0

499

136

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

323.0

14126

79916

M65.3

ICD-10 Finland

Trigger finger

7.9

323.0

1171

1159

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

323.0

4519

17774

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

323.0

10456

53934

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

323.0

13632

74258

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.4

323.0

5089

12767

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

323.0

4365

15263

R51.80

ICD-10 Finland

Headache

3.0

323.0

6626

18905

N02AJ06

ATC

codeine and paracetamol; systemic

2.7

323.0

15551

58689

J01FA06

ATC

roxithromycin; oral

1.8

323.0

13784

71112

R06AE07

ATC

cetirizine; oral

1.6

323.0

14944

83237

A02BC02

ATC

pantoprazole; systemic

2.6

323.0

24835

121841

R01AD09

ATC

mometasone; nasal

1.6

323.0

15431

85734

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.2

323.0

1532

2877

G44.2

ICD-10 Finland

Tension-type headache

2.7

323.0

5162

16035

L12

ICPC

Hand/finger symptom/complaint

2.5

323.0

5305

17554

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.2

323.0

2465

6177

M54.6

ICD-10 Finland

Pain in thoracic spine

2.9

323.0

2415

6636

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.6

323.0

1820

4012

M54.3

ICD-10 Finland

Sciatica

3.6

323.0

2224

4998

R52.2

ICD-10 Finland

Other chronic pain

6.2

323.0

1541

1985

N06AX16

ATC

venlafaxine; oral

2.3

323.0

5254

19136

N06AA09

ATC

amitriptyline; systemic

3.5

323.0

3645

8659

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

6.4

323.0

1765

2183

C10AA01

ATC

simvastatin; oral

1.6

323.0

11693

63070

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.1

323.0

3256

6479

SPAT1216

SPAT

Assessment of functional ability

2.2

323.0

4550

17042

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

323.0

10661

39255

M79.7

ICD-10 Finland

Fibromyalgia

12.2

323.0

1447

939

L29

ICPC

Musculoskeletal sympt/complt other

2.8

323.0

2580

7432

M01AE01

ATC

ibuprofen; systemic, rectal

2.0

323.0

32659

219771

N03AX12

ATC

gabapentin; oral

5.0

323.0

7888

14422

A02BC05

ATC

esomeprazole; systemic

2.2

323.0

14773

65641

SPAT1229

SPAT

Assessment of need for aid

2.7

321.6

2436

7107

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.7

320.9

1597

3454

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

320.8

3086

10300

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

320.6

4505

17910

H02AB04

ATC

methylprednisolone; systemic

2.0

319.9

4617

18558

R60.9

ICD-10 Finland

Oedema, unspecified

3.5

319.3

1695

3863

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.6

319.0

1600

3483

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

319.0

22600

142886

J01MA12

ATC

levofloxacin; systemic

1.9

318.7

5840

25686

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

316.8

4422

17527

S80.0

ICD-10 Finland

Contusion of knee

2.7

314.7

2379

6930

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

314.7

4497

17994

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.3

314.3

1779

4259

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

314.2

2715

8550

N04BC05

ATC

pramipexole; oral

2.8

313.6

2275

6460

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

313.4

5705

25017

B01AF01

ATC

rivaroxaban; oral

2.3

311.5

3322

11669

M76.6

ICD-10 Finland

Achilles tendinitis

4.1

310.5

1356

2613

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

310.4

3566

12974

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.2

310.3

3567

12982

ZXA10

NOMESCO Finland

Bilateral

1.9

309.1

5710

25157

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

309.0

6267

28508

S29

ICPC

Skin symptom/complaint other

1.9

308.6

5287

22672

N30.0

ICD-10 Finland

Acute cystitis

2.0

308.2

4413

17660

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

306.2

2495

7594

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.9

305.9

2151

5986

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

305.6

2909

9644

R05FB02

ATC

cough suppressants and expectorants

1.6

303.1

11551

62948

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

301.9

10946

58894

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.9

300.5

1083

1718

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

300.5

2625

8307

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.5

300.2

1554

3468

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

8.2

297.5

732

695

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

296.8

5897

26600

L11

ICPC

Wrist symptom/complaint

2.5

296.1

2686

8675

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

293.8

6151

28219

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

293.6

13002

73336

R03BA05

ATC

fluticasone; inhalant

1.8

292.9

5965

27116

T90

ICPC

Diabetes non-insulin dependent

1.8

291.6

6555

30760

B01AC04

ATC

clopidogrel; oral

2.0

290.6

4328

17561

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.1

290.3

3688

14011

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

290.2

10604

57036

D01

ICPC

Abdominal pain/cramps general

2.1

288.7

3733

14289

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

287.6

9537

50011

A11

ICPC

Chest pain NOS

2.6

287.4

2334

7083

SPAT1310

SPAT

Counselling related to known health issue

1.6

286.7

10314

55218

A06AD11

ATC

lactulose; oral

2.0

286.5

4240

17156

XA402

NOMESCO Finland

ENMG

5.0

283.6

1018

1607

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.9

283.2

1924

5229

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

283.0

7083

34308

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.7

281.5

2233

6681

J01CA08

ATC

pivmecillinam; oral

1.5

281.2

12288

68902

R74

ICPC

Upper respiratory infection acute

1.6

280.8

9895

52640

S97

ICPC

Chronic ulcer skin

3.1

280.7

1764

4548

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.6

280.5

1396

3014

M01AB55

ATC

diclofenac, combinations; oral

2.8

280.2

2008

5645

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

280.1

6208

28957

N03AE01

ATC

clonazepam; systemic

2.8

279.9

2000

5614

R50.9

ICD-10 Finland

Fever, unspecified

1.9

279.7

4693

19906

R96

ICPC

Asthma

2.4

279.2

2762

9323

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

278.4

2269

6894

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.6

278.0

1421

3136

H02AB07

ATC

prednisone; oral

1.9

277.1

4452

18576

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

276.8

4052

16306

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

276.5

2368

7401

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

25.8

276.4

423

127

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

3.6

276.1

1379

2986

WZA90

NOMESCO Finland

Other doctors statement

1.7

273.4

7588

37818

J01EA01

ATC

trimethoprim; systemic

1.7

273.1

7696

38519

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

272.8

7870

39647

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

271.8

4154

16996

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

271.7

3446

13060

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.4

270.9

1081

1907

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

270.5

2455

7918

A04

ICPC

Weakness/tiredness general

2.0

270.3

4212

17360

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

269.8

3014

10785

N17

ICPC

Vertigo/dizziness

2.2

269.3

3272

12168

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

269.1

3873

15469

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.0

268.6

1706

4428

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

268.0

8546

44200

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

268.0

2719

9288

WX290

NOMESCO Finland

Other blockade of nerve

1.5

266.8

15394

91508

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

6.8

265.7

742

855

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

265.5

4101

16834

N05CF02

ATC

zolpidem; oral

1.8

265.0

5541

25318

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

263.8

4393

18550

UKC02

NOMESCO Finland

Cystoscopy

1.9

263.7

4708

20388

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

263.6

3671

14459

Z50.1

ICD-10 Finland

Other physical therapy

3.0

263.6

1730

4591

C10AA07

ATC

rosuvastatin; oral

1.7

263.3

6533

31475

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

263.2

4344

18280

D07AC01

ATC

betamethasone; topical

1.6

262.4

10627

58293

E0000UV

ATC

1.5

262.2

12819

73419

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.9

262.1

1208

2440

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

7.8

261.8

662

657

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

261.5

8478

43990

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

7.3

261.3

691

735

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

261.0

5115

22866

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.0

260.5

1155

2253

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

11.0

259.7

543

382

KMAK

NOMESCO Finland

1.5

259.1

17710

108806

P01BA02

ATC

hydroxychloroquine; oral

2.4

259.0

2477

8205

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

259.0

12936

74385

R11

ICD-10 Finland

Nausea and vomiting

2.3

258.8

2675

9215

M89.0

ICD-10 Finland

Algoneurodystrophy

13.0

258.5

501

299

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.9

257.0

1163

2311

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.1

256.1

3412

13186

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.7

255.2

1916

5538

Z01.2

ICD-10 Finland

Dental examination

1.5

254.9

13691

79894

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

253.6

6415

31041

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

252.5

6953

34465

Z00.0

ICD-10 Finland

General medical examination

1.7

251.4

5830

27474

R03BA02

ATC

budesonide; inhalant

1.8

249.6

5571

25937

N01

ICPC

Headache

2.0

249.5

3727

15078

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

7.6

248.6

643

661

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

247.2

2737

9735

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

246.8

1990

5998

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

246.4

12479

71756

C07AA05

ATC

propranolol; systemic

1.7

246.1

6273

30387

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.1

245.5

1060

2017

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.1

244.7

852

1299

S21

ICPC

Skin texture symptom/complaint

2.0

244.0

3820

15729

M66.0

ICD-10 Finland

Rupture of popliteal cyst

18.5

243.8

412

172

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

242.8

2219

7169

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.7

241.6

1880

5548

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

240.2

7318

37220

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

239.7

3329

13068

SPAT1211

SPAT

Application of soft bandage

2.2

239.5

2878

10623

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.2

239.3

1008

1873

A98

ICPC

Health maint/preventive medicine

1.9

239.1

35339

255167

E66.8

ICD-10 Finland

Other obesity

2.7

239.0

1892

5641

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

238.3

3433

13677

N03AX09

ATC

lamotrigine; oral

2.7

237.6

1842

5423

A29

ICPC

General symptom/complaint other

2.0

236.9

3368

13347

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

236.5

5231

24245

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.7

236.3

1839

5426

D06

ICPC

Abdominal pain localized other

2.2

236.0

2653

9495

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

235.6

2089

6637

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

235.2

2549

8968

ZXD20

NOMESCO Finland

Day surgery

1.9

234.7

4016

17071

SPAT1262

SPAT

Handing over of treatment supplies

1.7

234.0

5361

25113

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

232.9

4947

22627

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

231.0

1847

5536

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

229.2

2391

8255

L09

ICPC

Arm symptom/complaint

3.0

229.0

1470

3835

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

228.8

2884

10860

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

7.8

228.3

577

572

R01AD08

ATC

fluticasone; nasal

1.5

227.7

8995

48712

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.0

227.3

1436

3706

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.3

227.2

2332

7986

XF402

NOMESCO Finland

ECG with work load test

2.0

226.5

3102

12094

M54.8

ICD-10 Finland

Other dorsalgia

3.1

226.3

1372

3440

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

5.4

226.1

748

1074

EBA00

NOMESCO Finland

Extraction of tooth

1.5

226.1

10764

60781

U02

ICPC

Urinary frequency/urgency

1.9

225.8

3780

15928

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

224.6

3169

12506

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

224.3

2930

11199

M01AC01

ATC

piroxicam; systemic, rectal

1.9

222.9

3744

15789

S22.3

ICD-10 Finland

Fracture of rib

2.5

222.7

2016

6473

N06AB10

ATC

escitalopram; oral

1.6

221.9

6658

33627

M75.8

ICD-10 Finland

Other shoulder lesions

3.8

221.8

1039

2126

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.6

221.5

1102

2374

R00.2

ICD-10 Finland

Palpitations

2.3

219.8

2268

7784

J20

ICD-10 Finland

Acute bronchitis

2.1

219.5

2922

11254

M10.9

ICD-10 Finland

Gout, unspecified

2.5

219.2

1898

5947

R55

ICD-10 Finland

Syncope and collapse

2.0

217.9

3148

12531

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

217.3

2164

7297

D11

ICPC

Diarrhoea

1.9

216.9

3664

15474

H03AA01

ATC

levothyroxine sodium; systemic

1.6

216.6

6754

34431

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.4

216.6

866

1529

G04BD12

ATC

mirabegron; oral

2.2

216.3

2604

9602

C09CA06

ATC

candesartan; oral

1.6

216.2

6196

30880

SPAT1312

SPAT

General health counselling

1.5

215.8

10369

58533

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

215.7

2400

8536

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

215.3

1687

4992

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

214.9

1147

2614

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

213.9

8578

46490

J45

ICD-10 Finland

Asthma

2.0

213.8

2986

11721

L90

ICPC

Osteoarthrosis of knee

2.7

212.8

1635

4781

L05

ICPC

Flank/axilla symptom/complaint

2.6

212.4

1720

5188

R03BA01

ATC

beclometasone; inhalant

1.8

212.1

4214

18811

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

12.0

211.6

425

275

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

2.1

211.2

2865

11111

R01AD12

ATC

fluticasone furoate; nasal

1.5

210.9

9584

53393

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.1

209.9

2744

10479

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

209.4

2188

7550

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

209.0

4506

20646

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

208.9

4142

18473

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

208.6

12759

75548

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.3

207.8

1182

2828

R21

ICPC

Throat symptom/complaint

1.6

207.0

6803

35094

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

9.0

206.5

481

416

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

6.5

206.5

590

702

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.2

206.0

861

1587

R52.0

ICD-10 Finland

Acute pain

3.3

205.9

1148

2705

R03AC03

ATC

terbutaline; inhalant

1.8

205.3

4326

19668

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

205.1

1243

3114

SPAT1097

SPAT

Recording of ECG

1.8

205.0

4028

17903

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

204.4

3135

12757

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

204.4

3663

15779

R06AX27

ATC

desloratadine; oral

1.5

204.4

8789

48305

A08

ICPC

Swelling

3.1

204.3

1262

3204

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

10.2

203.4

442

336

XF404

NOMESCO Finland

Ambulatory ECG

2.1

202.9

2705

10407

R35

ICD-10 Finland

Polyuria

2.4

202.1

1881

6121

M77.0

ICD-10 Finland

Medial epicondylitis

4.6

201.8

770

1296

M04AA01

ATC

allopurinol; systemic

1.9

201.7

3477

14767

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

201.1

1809

5778

R13

ICD-10 Finland

Dysphagia

2.4

200.9

1867

6069

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

200.5

1318

3491

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

25.5

200.3

307

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

200.1

23845

158957

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.1

199.9

2624

10027

R03BB04

ATC

tiotropium bromide; inhalant

2.0

199.8

2783

10898

H01

ICPC

Ear pain/earache

1.9

199.6

3427

14531

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

199.6

2822

11119

Z2446

NOMESCO Finland

Social worker

2.2

198.9

2318

8411

-1

NOMESCO Finland

1.5

198.7

11225

65263

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

198.5

4803

22763

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

198.3

5523

27241

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

197.6

5997

30262

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

197.4

3303

13876

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

197.1

8566

47121

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

196.8

1504

4381

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.3

196.4

805

1456

S70.0

ICD-10 Finland

Contusion of hip

3.3

196.2

1121

2689

R5599

NOMESCO Finland

Other rehabilitation service

3.7

194.9

955

2030

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.9

194.6

895

1801

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

194.0

6618

34385

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

193.4

7876

42670

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.3

193.0

2076

7255

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.8

192.9

901

1838

C10AX09

ATC

ezetimibe; oral

2.0

191.7

2815

11250

C01DA14

ATC

isosorbide mononitrate; oral

1.8

191.1

3707

16379

K07

ICPC

Swollen ankles/oedema

3.1

191.0

1191

3042

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

4.1

188.9

805

1511

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

188.5

2707

10721

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

188.0

6131

31468

R52.1

ICD-10 Finland

Chronic intractable pain

9.3

187.7

427

354

L04

ICPC

Chest symptom/complaint

2.4

187.7

1767

5777

WX402

NOMESCO Finland

General anaesthesia

1.6

187.2

5229

25770

R51

ICD-10 Finland

Headache

2.4

186.5

1741

5667

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

186.5

2120

7601

M19.8

ICD-10 Finland

Other specified arthrosis

3.6

186.5

945

2065

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

186.0

6480

33795

WX200

NOMESCO Finland

Interscalenous plexus blockade

6.1

186.0

561

718

M19.9

ICD-10 Finland

Arthrosis, unspecified

3.4

185.9

996

2275

A10BA02

ATC

metformin; oral

1.5

185.9

7591

41092

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

185.8

2266

8384

K08.80

ICD-10 Finland

Toothache NOS

2.0

185.5

2568

10020

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

11.2

185.1

383

264

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

7.0

184.8

501

553

N06AB03

ATC

fluoxetine; oral

1.8

184.6

3851

17413

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

4.9

184.0

659

1036

SPAT1255

SPAT

Intravenous administration of medicine

2.2

182.5

1992

7006

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

4.2

182.5

757

1385

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

182.4

7299

39303

WZC30

NOMESCO Finland

Teaching

1.8

182.4

3886

17682

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.0

182.3

1168

3039

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

181.8

2091

7533

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

181.8

4278

20064

N06AA10

ATC

nortriptyline; systemic

4.3

181.8

750

1365

N05CD07

ATC

temazepam; oral

1.8

181.3

3315

14342

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

180.9

8718

48872

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

180.5

1867

6398

R12

ICD-10 Finland

Heartburn

2.2

180.4

2116

7689

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.7

180.3

879

1860

C07AB02

ATC

metoprolol; systemic

1.6

180.2

5416

27188

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

179.4

1608

5123

P06

ICPC

Sleep disturbance

1.9

178.7

3033

12783

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

178.5

3277

14195

M01AB08

ATC

etodolac; oral

2.2

178.1

2057

7423

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.0

178.0

784

1517

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.5

177.9

1613

5170

A02BC04

ATC

rabeprazole; oral

2.0

177.7

2445

9510

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

176.8

2759

11273

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.2

176.5

2024

7281

A03

ICPC

Fever

1.6

176.3

5271

26411

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

176.2

1680

5527

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

4.4

176.1

711

1267

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.0

175.9

1106

2840

M50.3

ICD-10 Finland

Other cervical disc degeneration

4.3

175.8

719

1297

M23.8

ICD-10 Finland

Other internal derangements of knee

2.9

175.5

1190

3213

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.8

175.5

820

1673

M70.7

ICD-10 Finland

Other bursitis of hip

4.6

174.6

673

1144

AN1

Coronary angiography

1.9

174.6

2986

12612

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

174.3

2417

9428

M01AX01

ATC

nabumetone; oral

2.8

174.2

1225

3386

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.7

173.6

1336

3904

M15

ICD-10 Finland

Polyarthrosis

3.0

173.1

1137

3006

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.7

173.0

851

1814

A99

ICPC

Disease/condition unspecnature/site

2.1

173.0

2318

8917

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

172.9

2172

8131

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

172.0

2623

10619

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.8

171.8

1241

3488

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.4

171.0

924

2124

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.5

170.9

1494

4691

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

170.8

1995

7231

D07AC13

ATC

mometasone; topical

1.5

170.7

8691

49161

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

170.1

1939

6952

M76.0

ICD-10 Finland

Gluteal tendinitis

6.3

169.5

494

604

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.0

169.4

747

1447

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.1

169.1

1022

2552

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

168.5

5986

31273

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

168.4

4630

22657

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

168.2

1553

5022

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

167.9

3208

14069

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

167.5

2008

7360

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

166.3

1878

6703

C09AA05

ATC

ramipril; oral

1.5

165.9

6347

33726

M43.1

ICD-10 Finland

Spondylolisthesis

3.0

165.8

1082

2848

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

165.3

2314

9055

B01AF02

ATC

apixaban; oral

2.0

165.3

2320

9089

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.1

165.2

1027

2614

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

165.1

2983

12831

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.0

164.5

1029

2631

M35.7

ICD-10 Finland

Hypermobility syndrome

5.5

163.7

535

757

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

163.1

2360

9356

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.7

162.5

1198

3409

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

162.4

1759

6156

A07EC01

ATC

sulfasalazine; oral, rectal

2.0

162.3

2319

9146

L18

ICPC

Muscle pain

2.8

162.2

1158

3230

C09CA01

ATC

losartan; oral

1.5

161.1

6179

32823

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

161.0

847

1906

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

160.9

3237

14426

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

12.1

160.9

321

205

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

160.7

2520

10299

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

4.4

160.6

648

1154

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

160.5

3303

14826

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

160.4

171

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

160.4

2450

9916

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

6.8

159.8

440

497

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

159.8

1841

6629

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

159.7

2820

12030

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.0

159.7

1029

2686

R25.2

ICD-10 Finland

Cramp and spasm

3.7

159.6

763

1587

P03

ICPC

Feeling depressed

1.8

159.5

3022

13204

ZX120

NOMESCO Finland

Intravenous

1.9

158.5

2788

11876

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

158.4

1302

3948

SPAT1240

SPAT

Therapeutic discussion

1.7

157.9

3540

16317

J01DA06

ATC

[U] cefuroxime; systemic

1.6

157.8

4357

21317

K07.60

ICD-10 Finland

Snapping jaw

2.4

157.4

1516

5008

B01AB04

ATC

dalteparin; parenteral

2.4

157.3

1456

4711

J01MA14

ATC

moxifloxacin; systemic

1.9

157.3

2555

10577

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.9

157.1

710

1406

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

157.1

5290

27231

M01AH03

ATC

valdecoxib; oral

2.2

156.6

1728

6096

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.6

155.7

593

996

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

155.7

2144

8329

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

154.8

3516

16262

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.6

154.7

784

1712

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

3.0

154.6

973

2498

P20

ICPC

Memory disturbance

1.9

154.6

2558

10658

Z00.8

ICD-10 Finland

Other general examinations

2.0

154.3

2213

8734

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

154.2

1840

6726

D07AD01

ATC

clobetasol; topical

1.6

154.0

4323

21230

S83.2

ICD-10 Finland

Tear of meniscus, current

2.1

153.9

2023

7709

H57.1

ICD-10 Finland

Ocular pain

2.9

153.8

1030

2757

M75.2

ICD-10 Finland

Bicipital tendinitis

4.6

153.7

586

985

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

153.6

2914

12732

A10AE04

ATC

insulin glargine; parenteral

1.9

153.5

2640

11152

C08CA13

ATC

lercanidipine; oral

1.8

153.3

3192

14371

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

153.0

5345

27742

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.5

152.8

5757

30415

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

152.4

1175

3433

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

152.0

1760

6348

H02BX01

ATC

methylprednisolone, combinations; systemic

2.5

151.9

1274

3907

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

151.6

1987

7561

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

151.5

3057

13621

D02

ICPC

Abdominal pain epigastric

2.2

151.3

1710

6099

J46

ICD-10 Finland

Status asthmaticus

3.2

151.2

870

2095

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.3

150.9

610

1088

K59.0

ICD-10 Finland

Constipation

2.3

150.8

1558

5327

J05AB01

ATC

aciclovir; systemic

1.5

150.5

6023

32246

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.5

150.2

786

1761

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

150.0

1979

7550

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

149.4

1817

6697

D19

ICPC

Teeth/gum symptom/complaint

1.4

149.1

8049

45841

R09

ICPC

Sinus symptom/complaint

1.9

149.1

2344

9581

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.9

148.9

347

301

SPAT1283

SPAT

Restricted health certificate

1.5

148.8

6086

32729

A07AA02

ATC

nystatin; oral

2.2

148.7

1661

5890

XKD00

NOMESCO Finland

Uroflowmetry

1.6

148.5

4245

20934

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

148.3

2006

7730

SGA01

NOMESCO Finland

Tooth opening as first aid

1.6

148.1

4935

25302

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.4

148.1

1389

4524

M09AX01

ATC

hyaluronic acid; parenteral

2.6

148.0

1181

3521

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

147.8

1502

5094

SPAT1058

SPAT

PEF monitoring instruction

2.0

147.7

2241

9034

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.0

147.4

2012

7780

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

146.9

6510

35608

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

146.0

2546

10798

C05AA08

ATC

fluocortolone; rectal, topical

1.6

145.5

3954

19230

A03FA02

ATC

cisapride; oral, rectal

2.0

145.5

1997

7740

K85

ICPC

Elevated blood pressure

1.7

145.3

3592

17012

SPAT1325

SPAT

Vaccination

1.4

145.3

9692

57356

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

145.2

1584

5555

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

145.1

1539

5327

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

144.9

1535

5309

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

144.4

2083

8235

K04.0

ICD-10 Finland

Pulpitis

1.7

144.3

3103

14100

L60.0

ICD-10 Finland

Ingrowing nail

2.5

144.1

1285

4073

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

143.9

3917

19052

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

143.8

8922

52100

J01FA15

ATC

telithromycin; oral

1.8

143.6

2967

13311

L20

ICPC

Joint symptom/complaint NOS

2.8

143.4

1034

2899

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

143.4

2677

11621

SPAT1252

SPAT

Overall medication plan or its review

2.1

142.8

1861

7060

R07.0

ICD-10 Finland

Pain in throat

2.0

142.8

1933

7450

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

142.6

1609

5732

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

142.5

4140

20489

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

142.4

1437

4855

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

142.4

1540

5380

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

4.8

141.8

517

829

WX204

NOMESCO Finland

Axillary plexus blockaced

3.1

141.8

845

2088

TAB00

NOMESCO Finland

Lumbar puncture

2.3

141.7

1409

4726

N02AJ13

ATC

tramadol and paracetamol; systemic

4.0

141.2

616

1182

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.1

141.1

1691

6189

L84

ICPC

Back syndrome without radiat pain

2.5

141.0

1255

3975

SFA00

NOMESCO Finland

Small filling

1.6

140.8

3763

18206

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

140.7

2036

8056

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.9

140.5

637

1265

N05BA12

ATC

alprazolam; oral

1.8

140.3

2918

13114

ZY010

NOMESCO Finland

Hospital outpatient

2.1

140.2

1687

6185

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

140.0

2103

8442

L10

ICPC

Elbow symptom/complaint

2.4

139.9

1338

4400

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

139.8

149

N06AB06

ATC

sertraline; oral

1.7

139.5

3332

15615

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

139.3

1574

5608

R51.81

ICD-10 Finland

Facial pain NOS

3.5

139.3

714

1574

N03AF01

ATC

carbamazepine; oral, rectal

2.3

139.2

1491

5182

M05BA04

ATC

alendronic acid; oral

2.1

139.1

1769

6641

S20.2

ICD-10 Finland

Contusion of thorax

2.3

139.0

1416

4806

H29

ICPC

Ear symptom/complaint other

1.8

138.8

2670

11701

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

138.6

3463

16440

XQ800

NOMESCO Finland

Prick test

1.9

138.2

2331

9764

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

138.2

571

1041

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.3

138.0

461

670

S01

ICPC

Pain/tenderness of skin

2.5

138.0

1220

3850

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

137.9

3172

14697

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.7

137.9

510

831

A01AB09

ATC

miconazole; local oral

1.9

137.5

2338

9821

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

9.9

137.2

301

234

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

136.3

1911

7467

A02BA04

ATC

nizatidine; systemic

2.0

136.1

2017

8052

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.2

135.8

571

1058

WX892

NOMESCO Finland

Monitored bed care

1.9

135.8

2171

8917

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

135.8

2783

12443

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

135.4

1981

7871

NH1AD

NOMESCO Finland

Ankle and foot CT

3.5

135.2

701

1559

R4110

SPAT

3.1

135.1

841

2142

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

134.3

1313

4364

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.6

134.1

1060

3141

205

Kela drug reimbursment

Chronic hypertension

1.4

133.8

6877

38664

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

133.8

2044

8255

M22.4

ICD-10 Finland

Chondromalacia patellae

2.8

133.7

977

2763

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

133.5

1498

5321

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

132.8

11213

68795

S04

ICPC

Lump/swelling localized

1.8

132.0

2646

11745

T82

ICPC

Obesity

2.5

131.8

1181

3754

H92.0

ICD-10 Finland

Otalgia

2.2

131.5

1519

5465

G04CA02

ATC

tamsulosin; oral

1.5

131.4

5791

31542

W10

ICD-10 Finland

Fall on and from stairs and steps

2.2

130.9

1422

4974

RF210

NOMESCO Finland

2.9

130.7

878

2353

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.8

130.7

2761

12457

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

130.4

1353

4630

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

130.4

4349

22245

U07

ICPC

Urine symptom/complaint other

2.1

130.3

1545

5625

SPAT1202

SPAT

Intra-articular injection

3.1

130.1

809

2059

L92

ICPC

Shoulder syndrome

3.9

130.0

596

1196

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

130.0

9891

59619

R03BA08

ATC

ciclesonide; inhalant

1.9

129.8

2260

9566

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

129.1

3666

18002

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

128.7

1397

4885

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.9

128.6

853

2268

B02AA02

ATC

tranexamic acid; systemic

1.6

128.5

4298

21988

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.3

128.5

703

1631

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

128.1

2405

10442

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

128.0

1046

3158

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

127.7

1442

5132

N03AG01

ATC

valproic acid; systemic, rectal

2.0

127.7

1924

7723

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

127.3

1178

3807

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

127.1

1397

4913

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

127.0

2104

8748

R06.5

ICD-10 Finland

Mouth breathing

1.8

127.0

2462

10805

C03AA03

ATC

hydrochlorothiazide; oral

1.8

126.9

2321

9988

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

126.7

1338

4617

N02AC04

ATC

dextropropoxyphene; oral

2.7

126.6

956

2756

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.7

126.6

931

2643

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.6

126.5

639

1392

I20.09

ICD-10 Finland

Unstable angina

2.2

126.2

1399

4939

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.3

126.1

421

612

R06AX22

ATC

ebastine; oral

1.5

125.9

4994

26568

R29

ICPC

Respiratory symptom/complaint other

2.0

125.6

1797

7070

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.8

125.5

912

2569

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

125.4

981

2890

M75.5

ICD-10 Finland

Bursitis of shoulder

3.9

125.4

572

1143

R03AC13

ATC

formoterol; inhalant

2.2

125.3

1358

4743

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.0

125.3

811

2122

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

125.2

1227

4083

K29

ICPC

Cardiovascular sympt/complt other

2.5

124.9

1080

3365

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

124.9

3580

17611

G04BD08

ATC

solifenacin; oral

2.1

124.7

1594

5992

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.2

124.3

1341

4673

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

124.0

2344

10195

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

123.8

1042

3199

N06AA12

ATC

doxepin; systemic

2.2

123.6

1411

5047

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.8

123.5

857

2346

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.5

123.4

628

1376

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

123.4

2930

13680

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

123.2

1945

7945

73398

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Alii definiti

+∞

122.9

131

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

122.9

2434

10752

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

122.8

2374

10401

H13

ICPC

Plugged feeling ear

1.5

122.8

4539

23753

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

122.1

2517

11259

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

30.4

121.8

178

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

121.8

3921

19855

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

4.0

121.5

530

1017

G50.1

ICD-10 Finland

Atypical facial pain

4.0

121.4

532

1025

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.2

120.9

508

941

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.8

120.9

845

2323

ACC53

NOMESCO Finland

Release of ulnar nerve

4.7

120.8

455

756

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

120.8

2669

12198

NF3AA

NOMESCO Finland

Femur X-ray examination

3.7

120.6

586

1236

S22

ICPC

Nail symptom/complaint

2.1

120.5

1569

5940

M62.6

ICD-10 Finland

Muscle strain

2.9

120.4

804

2146

K80

ICPC

Cardiac arrhythmia NOS

1.9

120.3

1824

7337

C09AA02

ATC

enalapril; systemic

1.5

120.1

4933

26420

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.5

119.9

1058

3333

B01AB10

ATC

tinzaparin; parenteral

1.9

119.7

1881

7668

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

109.9

119.5

143

M19.2

ICD-10 Finland

Other secondary arthrosis

5.5

119.4

385

537

M79.5

ICD-10 Finland

Residual foreign body in soft tissue

4.4

119.0

472

827

C03DA01

ATC

spironolactone; oral

1.7

118.8

2672

12273

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

54.2

118.7

155

UJD02

NOMESCO Finland

Gastroscopy

2.2

118.6

1308

4604

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.7

118.2

437

712

J01MA06

ATC

norfloxacin; oral

1.6

118.1

3610

18037

NG2AA

NOMESCO Finland

Patella X-ray examination

3.1

118.1

722

1815

207

Kela drug reimbursment

Chronic arrhythmias

1.6

117.9

3188

15429

P01

ICPC

Feeling anxious/nervous/tense

1.6

117.6

3357

16479

1220

FHL

Arthroscopy

2.5

117.3

1044

3305

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

116.9

1250

4335

SPAT1053

SPAT

Memory test

1.6

116.7

3049

14615

F29

ICPC

Eye symptom/complaint other

1.8

116.7

2265

9933

A97

ICPC

No disease

1.5

116.2

4251

22171

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.9

116.0

523

1034

A10BH01

ATC

sitagliptin; oral

1.8

115.8

2358

10499

U01

ICPC

Dysuria/painful urination

1.9

115.7

1980

8321

G56.4

ICD-10 Finland

Causalgia

13.0

115.5

222

131

R04.0

ICD-10 Finland

Epistaxis

1.9

115.4

1796

7292

M75

ICD-10 Finland

Shoulder lesions

2.4

115.4

1086

3540

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

115.3

2719

12658

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

115.0

4722

25265

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.0

114.9

745

1950

N39.3

ICD-10 Finland

Stress incontinence

2.0

114.7

1677

6652

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

114.4

2718

12683

H02

ICPC

Hearing complaint

1.7

114.3

2734

12780

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

114.0

2052

8774

J02AC02

ATC

itraconazole; systemic

1.5

113.6

4969

26940

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10186

50324

1.59

321.89

1.8

1.6

pmol/l

39834263.9

31940788.1

0.59

8425

41781

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2233

6606

2.52

317.85

2.3

2.4

g/l

0.7

0.9

1.97

1946

5638

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3717

13704

2.04

314.70

1.6

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2304

7011

2.45

308.93

1.8

1.7

g/l

1.2

4.97

2193

6667

(3022217) INR in Platelet poor plasma by Coagulation assay

7717

28507

2.15

307.65

25.9

23.2

inr

1.3

1.4

0.78

1128

4040

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

44091

286739

2.95

307.65

13.3

9.1

u/l

26.1

26.3

1.10

43079

276335

(3019198) Lymphocytes [#/volume] in Blood

26727

130426

2.12

307.65

6.9

5.7

e9/l

1.9

0.13

23795

114621

(3019550) Sodium [Moles/volume] in Serum or Plasma

43707

269902

3.60

307.65

23.2

13.7

mmol/l

139.5

139.6

9.63

43110

262025

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19684

86996

2.10

307.65

4.6

3.2

ng/l

42.0

63.5

2.57

13347

55077

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

41121

265075

2.01

307.65

5.3

4.3

mmol/l

2.7

2.8

49.51

38186

245586

(3009508) Creatinine [Moles/volume] in Urine

14907

74988

1.64

307.65

3.6

3.2

mmol/l

7.4

8.0

2.57

12469

63331

(3014576) Chloride [Moles/volume] in Serum or Plasma

7280

29067

1.96

307.65

7.7

7.1

mmol/l

104.5

0.24

7127

28441

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6081

22315

2.12

307.65

2.9

2.4

u/l

41.1

42.0

0.06

5225

19134

(3002032) Base excess in Venous blood by calculation

5631

21813

1.99

307.65

5.3

3.9

mmol/l

1.8

0.14

4751

17709

(3035941) MCH [Entitic mass]

45260

305636

3.18

307.65

30.3

17.7

30.2

2.19

44935

300984

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2560

7765

2.46

307.65

2.1

2.3

g/l

3.8

3.9

1.14

1910

5529

(3031040) Bacteria [#/volume] in Urine by Automated count

32422

169860

2.24

307.65

5.9

4.0

e6/l

1216.8

1416.3

0.20

332

2464

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4756

18324

1.98

307.65

2.7

2.2

ug/l

6.1

7.9

6.66

4154

15867

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

30202

179816

1.61

307.65

3.7

2.9

u/l

49.5

45.4

11.36

28401

168809

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

36659

193291

2.72

307.65

8.9

7.1

u/l

78.2

78.3

0.16

34886

181526

(40761511) CBC panel - Blood by Automated count

43538

283059

2.62

307.65

18.8

11.4

—

(3035350) Ketones [Presence] in Urine by Test strip

24286

126265

1.81

307.65

4.5

3.3

estimate

0.0

2.69

4822

23896

(3003396) Base excess in Arterial blood by calculation

6428

25725

1.94

307.65

7.2

7.5

mmol/l

1.1

1.0

1.33

5199

20073

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2866

7195

3.00

307.65

2.6

2.3

ug/l

379.4

600.9

1.52

2672

6718

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1564

3636

3.18

307.65

1.8

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

25106

124148

2.00

307.65

7.2

5.9

27.8

28.2

8.25

23535

115893

(3007853) Bacteria identified in Skin by Aerobe culture

7819

27838

2.24

307.65

2.0

1.7

—

(3018095) Leukocytes [#/volume] in Urine

19575

88175

2.04

307.65

4.7

3.4

e6/l

73.2

103.1

6.75

14558

60313

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

35422

203031

2.08

307.65

4.6

3.8

pmol/l

14.7

0.17

32666

185150

(3015736) pH of Urine

19363

97818

1.74

307.65

4.1

3.1

5.8

5.7

0.27

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

26954

126483

2.28

307.65

6.4

6.1

umol/l

10.5

11.7

43.55

25668

119413

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9651

42349

1.82

307.65

2.9

3.1

mmol/l

2.5

2.4

3.21

8297

36873

(3013115) Eosinophils [#/volume] in Blood

26985

130636

2.17

307.65

7.1

5.9

e9/l

0.2

2.23

23974

114356

(3023368) Bacteria identified in Blood by Culture

15546

62756

2.18

307.65

5.2

4.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

18024

66954

2.54

307.65

2.5

2.0

u/l

187.1

217.3

4.16

17071

62667

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12989

59949

1.78

307.65

2.8

2.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8015

32155

1.97

307.65

3.0

2.5

21.3

23.0

22.68

6883

27573

(3000494) Fungus identified in Specimen by Culture

6476

27612

1.81

307.65

1.6

1.4

—

(3022096) Basophils/100 leukocytes in Blood

23988

115416

2.03

307.65

7.1

5.9

0.7

0.31

22476

107677

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9582

38146

2.03

307.65

3.5

3.6

mmol/l

0.8

3.52

8926

35605

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

14283

60856

2.00

307.65

2.5

2.2

mg/l

2.9

0.52

12379

51750

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11388

37782

2.56

307.65

1.4

1.2

iu/ml

33.1

36.5

0.58

3376

11862

(3010813) Leukocytes [#/volume] in Blood

45268

305781

3.18

307.65

30.5

17.8

e9/l

6.9

6.7

34.14

44545

296105

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

9770

38483

2.06

307.65

3.5

2.7

e6/l

3.1

0.24

5386

20381

(3023103) Potassium [Moles/volume] in Serum or Plasma

43750

270767

3.60

307.65

23.4

13.8

mmol/l

4.0

26.93

43089

262295

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2130

4763

3.34

307.65

1.5

1.4

—

(3012544) pH of Venous blood

5781

22634

1.97

307.65

5.2

4.0

7.4

2.68

110

(3026782) Osmolality of Urine

11740

47541

2.05

307.65

3.3

2.6

mosm/kgh2o

531.8

552.9

19.11

10132

40336

(3015377) Calcium [Moles/volume] in Serum or Plasma

17179

80958

1.84

307.65

3.4

mmol/l

2.4

1.45

15053

71105

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

12282

57687

1.73

307.65

1.3

u/ml

1.6

1.8

0.89

3135

15743

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2898

8433

2.58

307.65

1.3

1.2

u/ml

1.1

0.9

0.29

300

622

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6398

26866

1.84

307.65

4.1

4.3

u/l

239.4

244.3

1.52

6042

25445

(3020630) Protein [Mass/volume] in Serum or Plasma

5088

17389

2.25

307.65

2.4

2.6

g/l

66.4

66.5

0.91

4608

15807

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4201

14230

2.25

307.65

1.3

1.2

au/ml

54.2

47.6

0.55

642

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6444

25694

1.94

307.65

7.2

7.5

kpa

5.1

2.39

6163

24512

(40768804) Tissue Pathology biopsy report

19148

103991

1.56

307.65

2.2

2.0

—

(3002385) Erythrocyte distribution width [Ratio]

36322

228576

1.67

307.65

24.9

14.8

13.8

13.6

65.67

35880

223316

(3013826) Glucose [Moles/volume] in Serum or Plasma

29707

144982

2.32

307.65

5.9

4.5

mmol/l

6.6

6.7

0.73

28300

133475

(3026008) Bacteria identified in Urine by Culture

16810

72714

2.05

307.65

3.7

2.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10456

40611

2.11

307.65

3.3

2.6

e6/l

1.0

1.2

1.33

6066

22365

(3044889) 12 lead EKG panel

31262

175209

1.87

307.65

4.3

3.4

—

(3023520) Reticulocytes [#/volume] in Blood

4717

18683

1.92

307.65

2.7

e9/l

71.1

69.2

2.70

3436

13937

(40768797) Stomach Pathology biopsy report

8070

31143

2.06

307.65

1.3

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

33371

178356

2.23

307.65

5.5

3.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

23975

106622

2.28

307.65

7.0

5.9

mmol/l

1.2

3.19

22170

96489

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7005

27691

1.98

307.65

2.9

2.8

umol/l

7.0

9.1

13.37

5971

23920

(3000991) Gas panel - Venous blood

5220

20020

2.00

307.65

8.9

8.5

—

(3000850) Epithelial cells [#/volume] in Urine

12616

50299

2.11

307.65

3.0

2.5

e6/l

5.8

5.9

0.16

11149

43670

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21231

101997

1.92

307.65

2.6

2.2

nmol/l

4331.3

76.1

0.50

19268

92415

(3021960) Folate [Moles/volume] in Serum or Plasma

12711

52850

2.01

307.65

1.7

1.5

nmol/l

20.2

0.12

11128

45650

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5651

21902

1.98

307.65

5.2

3.9

kpa

5.9

5.8

6.92

5495

21217

(3018418) pH of Serum or Plasma

16716

69283

2.16

307.65

4.7

4.0

7.4

0.35

3062

13552

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11620

43631

2.23

307.65

4.6

3.4

ng/l

271.4

610.9

11.75

8666

32276

(3019309) Folate [Moles/volume] in Red Blood Cells

10181

41926

1.97

307.65

1.9

1.7

nmol/l

1152.8

1170.4

1.03

7828

31615

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2419

7287

2.48

307.65

2.1

2.3

g/l

9.9

10.5

8.55

2044

6077

(3013707) Erythrocyte sedimentation rate by Westergren method

36071

186425

2.74

307.65

5.1

3.5

mm/h

12.7

11.5

42.29

33992

172123

(3033658) Prothrombin time (PT) actual/Normal

14706

62858

2.01

307.65

5.0

3.8

91.0

90.5

1.45

14321

61302

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9928

36679

2.21

307.65

2.1

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4725

18161

1.98

307.65

3.1

2.8

ng/l

209.9

209.0

0.04

4289

16514

(3016502) Oxygen saturation in Arterial blood

5787

22784

1.95

307.65

7.5

8.0

95.5

95.7

1.29

5588

21938

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8588

34722

1.97

307.65

2.9

2.4

g/l

2.3

2.4

1.85

7944

32037

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

40451

260913

1.89

307.65

4.8

4.0

mmol/l

4.6

4.7

49.33

37848

243172

(3001122) Ferritin [Mass/volume] in Serum or Plasma

22654

117623

1.76

307.65

3.4

2.8

ug/l

116.3

115.9

0.09

20984

109666

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3346

11604

2.17

307.65

5.9

4.4

mmol/l

24.2

24.1

1.07

3026

10523

(3030467) Casts [#/volume] in Urine by Automated count

16147

67351

2.12

307.65

3.9

2.9

e6/l

0.3

0.4

6.18

12519

49676

(3006315) Basophils [#/volume] in Blood

26345

126363

2.16

307.65

6.8

5.7

e9/l

0.0

2.95

22941

109032

(3019069) Monocytes/100 leukocytes in Blood

24642

119944

2.03

307.65

7.3

6.1

8.5

0.21

23183

112455

(3000963) Hemoglobin [Mass/volume] in Blood

45261

305844

3.16

307.65

30.7

17.9

g/l

133.4

135.7

207.84

44943

301216

(3037522) Nuclear Ab [Titer] in Serum

9024

31378

2.34

307.65

1.4

1.3

titre

491.0

555.3

2.40

1792

6191

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

17561

74840

2.12

307.65

3.0

2.5

u/l

55.1

59.3

11.57

16406

68841

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

21325

96569

2.10

307.65

2.2

1.9

pmol/l

95.6

0.07

11348

51296

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

38836

235362

2.14

307.65

6.5

5.1

mmol/mol

40.1

39.1

84.26

36315

218393

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5736

21635

2.05

307.65

2.2

nmol/l

360.7

381.6

12.20

5294

19973

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

38867

249687

1.74

307.65

4.2

3.6

mmol/l

1.4

1.3

83.99

35958

230591

(3011397) Hemoglobin [Presence] in Urine by Test strip

12419

57599

1.76

307.65

4.2

3.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

29401

146973

2.20

307.65

9.9

9.0

e9/l

4.2

4.1

8.36

25882

127792

(3042936) Bacteria identified in Isolate by Culture

9196

31949

2.35

307.65

2.4

1.9

—

(3044941) Cell count panel - Synovial fluid

1413

2714

3.85

307.65

1.5

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7098

24818

2.26

307.65

2.0

1.7

—

(3021589) Normoblasts [#/volume] in Blood

22220

115979

1.73

307.65

11.7

8.9

e9/l

0.0

0.78

18213

94840

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

23761

120836

1.86

307.65

4.6

3.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

40126

258942

1.85

307.65

4.7

3.9

mmol/l

1.4

1.5

41.64

37335

240344

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3919

12818

2.32

307.65

1.8

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

24238

126729

1.79

307.65

6.0

4.5

estimate

0.0

5.11

4948

24495

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2566

7779

2.47

307.65

2.1

2.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5340

21091

1.94

307.65

7.9

8.3

g/l

120.9

121.6

1.43

5181

20340

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4642

16411

2.16

307.65

4.1

3.9

ng/l

93.4

90.4

1.11

4050

14185

(3021788) Differential panel - Synovial fluid

1651

3211

3.82

307.65

1.6

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6273

25816

1.87

307.65

2.7

2.6

1.8

1.7

6.74

5557

22809

(3002582) Erythrocytes [#/volume] in Urine

17364

74062

2.11

307.65

4.0

3.0

e6/l

57.2

102.1

4.00

13725

55759

(3004588) Protein electrophoresis panel - Serum or Plasma

4269

13799

2.36

307.65

2.2

2.4

—

(3007461) Platelets [#/volume] in Blood

45246

305374

3.18

307.65

30.5

17.8

e9/l

255.4

253.2

9.88

44594

296615

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

17958

98721

1.51

307.65

4.9

3.4

—

(36304419) Bacteria [Presence] in Urine

15756

65866

2.10

307.65

3.9

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4785

16438

2.23

307.65

1.8

1.6

—

(3012516) Albumin [Mass/volume] in Urine

13521

67352

1.64

307.65

3.5

3.2

mg/l

641.1

366.9

6.22

8835

42607

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

43739

267811

3.78

307.65

21.5

12.0

mg/l

21.1

24.1

73.16

37710

206399

(40758558) Short blood count panel - Blood

13867

63179

1.83

307.65

7.4

7.0

—

(42870588) Differential panel, method unspecified - Blood

18987

84455

2.05

307.65

6.7

5.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

14899

60762

2.13

307.65

2.8

2.5

umol/l

3002.8

4777.6

7.29

12825

53274

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2570

7783

2.47

307.65

2.1

2.3

g/l

7.4

7.3

0.75

1995

5798

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2458

7317

2.51

307.65

2.2

2.3

g/l

3.1

0.13

1954

5695

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17274

83602

1.78

307.65

3.5

3.2

u/l

33.1

33.7

0.27

16384

79226

(3007164) IgA [Mass/volume] in Serum or Plasma

10850

50168

1.73

307.65

1.5

1.4

g/l

2.3

0.05

6319

31084

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

16982

49709

3.31

307.65

2.1

1.7

mg/l

1.1

1.3

13.87

13128

37494

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7540

31033

1.90

307.65

6.8

5.9

mmol/l

1.1

1.0

4.92

7063

28953

(3027801) Oxygen [Partial pressure] in Arterial blood

6440

25681

1.94

307.65

7.2

7.5

kpa

12.0

12.7

24.31

6163

24483

(3048689) Calprotectin [Mass/mass] in Stool

7290

31327

1.81

307.65

2.3

2.5

ug/g

122.9

132.4

1.38

5760

24683

(3032080) INR in Blood by Coagulation assay

21501

94182

2.20

307.65

10.6

8.3

inr

1.2

0.51

6636

28001

(3044640) Blood type and Crossmatch panel - Blood

16852

79763

1.82

307.65

2.9

2.2

—

(3013512) EKG study

13150

66780

1.59

307.65

4.5

3.5

—

(3026361) Erythrocytes [#/volume] in Blood

45260

305713

3.17

307.65

30.5

17.8

e12/l

4.4

4.5

172.02

44515

296045

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

40500

252510

2.19

307.65

5.0

4.1

mmol/l

6.0

5.8

69.94

37440

231608

(3006504) Eosinophils/100 leukocytes in Blood

24560

119230

2.03

307.65

7.1

5.8

2.8

0.78

23028

111181

(3001604) Monocytes [#/volume] in Blood

26235

125808

2.16

307.65

6.8

5.7

e9/l

0.6

1.50

22857

108587

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

26072

118406

2.34

307.65

7.7

6.4

mmol/l

1.2

5.61

22512

99148

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

40299

247765

2.27

307.65

18.6

11.4

ml/min/173m2

82.3

84.3

54.62

34763

200879

(3024354) Oxygen [Partial pressure] in Venous blood

4677

18020

1.97

307.65

4.6

3.4

kpa

4.7

0.12

4517

17388

(3022948) Iron [Moles/volume] in Serum or Plasma

9244

37782

1.96

307.65

2.9

2.4

umol/l

12.4

13.9

2.22

8573

35004

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10875

35050

2.62

307.65

1.4

1.2

u/ml

12.3

11.7

0.25

3882

14053

(3014111) Lactate [Moles/volume] in Serum or Plasma

5561

20257

2.12

307.65

7.2

mmol/l

1.3

1.4

0.79

5381

19467

(3000475) Leukocytes [#/volume] in Synovial fluid

2044

4101

3.72

307.65

1.7

1.6

e6/l

12476.8

14067.0

0.73

1463

2988

(3029937) Albumin [Presence] in Urine by Test strip

13120

67835

1.55

307.65

5.1

3.6

estimate

0.0

1.06

4787

23443

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

40353

243614

2.44

307.65

5.7

4.4

mu/l

1.9

2.2

3.30

37647

224303

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7107

24653

2.28

307.65

2.0

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15024

61242

2.14

307.65

3.3

2.9

ng/l

1462.7

1446.2

0.13

12761

51952

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4563

15603

2.23

307.65

2.4

2.3

au/ml

22.9

23.3

0.07

181

1049

(3020682) Albumin/Creatinine [Ratio] in Urine

14180

70982

1.64

307.65

4.3

4.0

mg/mmol

12.2

9.3

5.86

8890

45240

(3024731) MCV [Entitic volume]

45257

305683

3.17

307.65

30.4

17.7

91.1

90.6

87.68

44930

301013

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9221

36187

2.05

307.65

2.6

2.1

30.1

29.8

3.38

8983

35115

(3009261) Glucose [Presence] in Urine by Test strip

24418

128030

1.79

307.65

4.5

3.3

estimate

0.0

0.15

4812

23841

(3020564) Creatinine [Moles/volume] in Serum or Plasma

44236

284896

3.26

307.65

23.3

13.9

umol/l

77.5

75.9

15.69

44225

284730

(3024561) Albumin [Mass/volume] in Serum or Plasma

22384

104354

2.06

307.65

5.3

4.8

g/l

35.4

35.7

9.37

20902

96602

(3018010) Neutrophils/100 leukocytes in Blood

24820

122168

2.00

307.65

6.9

5.7

57.4

57.1

3.03

23333

114505

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2072

6032

2.55

304.56

2.1

2.2

g/l

37.7

0.28

1814

5147

(3008898) HLA-B27 [Presence]

2480

7858

2.35

304.32

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

4516

18026

1.90

304.21

2.7

g/l

10.3

10.7

8.91

4123

16512

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2247

6823

2.45

302.53

1.8

1.7

g/l

0.2

2.04

2136

6464

(3019150) Specific gravity of Urine by Refractometry

10680

54081

1.55

300.03

4.9

3.6

kg/l

1.0

0.53

1684

8321

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12258

64029

1.52

298.65

1.7

1.6

mmol/l

1.5

1.4

22.11

10279

54165

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2853

9721

2.19

295.16

1.5

1.6

u/ml

13.6

14.6

0.12

297

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2007

5859

2.54

293.16

2.2

g/l

0.0

0.31

1857

5325

(3020779) Urea [Moles/volume] in Serum or Plasma

5031

21095

1.81

289.44

8.7

7.4

mmol/l

9.9

9.5

3.14

4788

20057

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1882

5407

2.58

283.78

2.2

2.3

g/l

0.0

0.14

1733

4893

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1859

5332

2.58

281.22

2.2

2.3

g/l

0.0

0.00

1726

4882

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2133

6689

2.37

267.11

1.9

1.8

—

(3036489) Thrombin time

2727

9492

2.14

266.81

2.5

2.2

21.3

21.5

0.62

2344

8299

(40760892) CBC W Ordered Manual Differential panel - Blood

11139

58171

1.50

265.89

4.9

4.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

29743

186214

1.43

264.89

3.5

3.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3830

15181

1.90

261.57

7.8

7.6

mmol/l

24.9

24.7

3.03

3799

15023

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3221

12076

2.00

258.49

8.8

9.8

mmol/l

24.4

24.3

0.74

3020

11287

(3052851) Hemolysis interference index of Serum or Plasma

2207

7133

2.30

257.99

3.4

3.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1984

6145

2.39

255.14

1.4

ug/g

280.3

271.3

1.02

1122

3511

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1028

2219

3.40

254.79

1.6

1.5

57.1

57.4

0.07

676

1429

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5470

24325

1.71

254.72

4.1

3.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3621

14262

1.91

251.64

9.1

9.6

93.6

94.0

2.91

3606

14204

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2836

10293

2.06

248.40

1.8

1.7

g/l

1.6

1.5

1.93

2439

8751

(3022145) Colonoscopy Study observation

5900

26968

1.67

247.44

1.3

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3221

12258

1.97

247.40

8.8

10.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

3862

15684

1.85

243.93

1.4

1.3

u/ml

193.6

270.4

5.58

3594

14510

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3589

14238

1.89

243.73

9.1

9.5

0.6

0.7

4.57

3566

14148

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2848

10430

2.04

243.32

4.0

2.9

1.4

1.3

5.20

2832

10378

(3019060) Gas panel - Arterial blood

3604

14354

1.88

241.74

4.7

4.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2788

10218

2.03

237.54

4.0

2.9

0.6

0.7

1.64

2686

9836

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3564

14253

1.87

235.82

9.0

9.4

1.4

1.36

3540

14152

(3004119) Hemoglobin [Mass/volume] in Venous blood

3449

13726

1.88

231.48

4.5

3.3

g/l

127.9

129.4

3.37

3365

13424

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5068

22647

1.69

230.20

2.3

g/l

0.2

1.45

4648

21075

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1907

6076

2.32

229.85

1.3

u/ml

28.8

40.1

0.97

404

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1643

4918

2.47

227.00

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1643

4922

2.46

226.61

1.4

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2238

7675

2.16

226.39

1.6

titre

237.7

290.0

0.40

317

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3642

14858

1.84

225.97

4.0

3.9

kpa

5.2

5.1

3.94

3394

13761

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1935

6253

2.29

225.73

1.3

—

(3009343) pH of Capillary blood

3597

14687

1.83

222.42

4.0

3.8

7.4

0.30

564

1904

(36660697) Celiac disease serology panel - Serum

4656

20551

1.71

220.68

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3490

14227

1.84

216.69

3.9

3.8

mmol/l

1.8

1.6

1.12

2598

10332

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2174

7501

2.15

216.40

3.6

3.3

u/ml

0.3

1.16

1276

4181

(3017181) Myelocytes/100 leukocytes in Blood

4599

20380

1.70

214.48

4.2

4.1

0.9

1.0

0.17

1319

5650

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10075

53476

1.46

213.83

1.8

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

38325

254950

1.48

212.35

22.5

13.0

39.4

39.9

28.31

27956

192509

(40761535) Cells panel - Urine sediment

4266

18569

1.73

212.12

4.0

3.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1748

5579

2.31

209.58

1.3

u/ml

8.7

9.6

0.19

238

893

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

580

951

4.45

208.13

1.5

1.3

u/l

5.8

6.1

0.24

488

797

(3028026) IgM [Mass/volume] in Serum or Plasma

3426

14059

1.82

207.89

1.9

g/l

1.3

0.85

3107

12860

(3002179) Metamyelocytes/100 leukocytes in Blood

4237

18518

1.72

207.38

4.1

3.9

0.6

0.7

1.95

961

4051

(4010399)

3845

16350

1.76

207.20

1.5

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2278

8155

2.07

205.97

2.7

2.5

94.4

91.4

7.79

2094

7622

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1724

5516

2.31

205.48

1.3

u/ml

11.8

6.4

0.84

161

591

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2981

11747

1.89

205.30

2.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3757

15974

1.76

202.32

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2574

9717

1.97

201.04

1.9

2.0

u/l

39.3

0.02

2310

8683

(3021440) Promyelocytes/100 leukocytes in Blood

4365

19414

1.69

200.03

4.3

4.1

0.1

0.31

1228

5239

(3041096) Erythrocytes [Presence] in Urine by Automated

12703

71040

1.40

199.89

4.2

2.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2113

7455

2.10

198.33

3.2

2.6

185.7

185.3

0.07

1973

7102

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1458

4405

2.44

197.20

1.3

1.2

u/ml

3.8

17.3

1.45

(3025941) Bacteria identified in Stool by Culture

3470

14562

1.78

195.05

1.3

1.2

—

(3000492) Spirometry study

5183

24260

1.61

194.31

1.5

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1864

6317

2.18

193.64

1.5

1.4

iu/ml

20.7

12.5

0.94

154

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1902

6512

2.16

192.62

3.2

3.4

mg/l

38.1

47.0

1.72

1562

5202

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3313

13767

1.80

192.35

7.2

7.1

mmol/l

24.8

24.5

5.13

3117

12828

(3034860) Kappa light chains.free [Mass/volume] in Serum

1902

6531

2.15

191.20

3.2

3.4

mg/l

79.7

62.9

0.23

1557

5213

(3025159) Blasts/100 leukocytes in Blood

4128

18318

1.69

190.26

4.3

4.2

0.2

0.02

1033

4424

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4348

19569

1.67

190.01

4.4

3.8

mmol/l

1.2

1.58

3826

17016

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1458

4501

2.39

188.11

1.3

1.2

u/ml

5.1

5.8

0.09

359

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1852

6341

2.16

187.47

3.1

3.4

ratio

2.8

5.7

0.92

161

460

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4193

18857

1.67

183.42

3.1

2.5

ml/min/173m2

65.5

67.7

2.75

1780

7253

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1916

6733

2.10

181.43

1.9

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1463

4599

2.34

181.24

1.3

1.2

u/ml

42.2

43.9

0.13

160

435

(3022621) pH of Urine by Test strip

3625

15743

1.72

180.28

3.5

2.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

771

1733

3.25

179.33

1.5

28.5

32.1

1.78

493

1112

(3024928) Oxygen saturation in Venous blood

1488

4764

2.30

176.78

4.5

3.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

727

1591

3.34

176.28

1.4

e6/l

123025.6

105670.0

0.25

518

1070

(3045414) Leukocytes [Presence] in Urine

2628

10452

1.87

175.09

2.0

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3657

16084

1.70

173.42

3.1

3.5

pmol/l

4.4

4.5

12.91

3216

14434

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1726

5958

2.14

170.93

1.4

mg/l

510.0

536.4

0.52

1654

5677

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2249

8706

1.91

162.41

2.0

ug/l

2.0

2.5

0.87

1943

7669

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1557

5283

2.17

160.87

1.5

e6/l

29.2

30.3

0.04

1217

4060

(3003327) Ova and parasites identified in Stool by Light microscopy

2203

8499

1.92

160.67

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1557

5287

2.17

160.56

1.6

1.5

e6/l

1298.6

2346.3

0.62

1276

4280

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1008

2817

2.62

159.77

6.7

6.1

mg/l

11.7

11.3

1.84

927

2593

(4306422)

1212

3766

2.36

153.89

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2506

10218

1.82

153.74

1.1

u/ml

1.3

11.4

1.92

156

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1214

3808

2.34

150.91

1.3

1.2

u/ml

4.0

0.07

545

1707

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1519

5248

2.13

149.87

1.4

1.3

mmol/l

3.7

0.39

1420

4936

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1203

3780

2.34

148.95

1.1

—

(3019225) pH of Specimen

4629

22383

1.55

148.35

4.8

4.0

—

(3014051) Protein [Presence] in Urine by Test strip

1463

5048

2.13

144.77

2.3

2.0

—

(3003338) MCHC [Mass/volume]

35459

236909

1.34

144.27

26.8

15.3

g/l

331.5

332.7

109.41

35251

234842

(3007930) Methemoglobin/Hemoglobin.total in Blood

2238

8991

1.84

143.77

4.9

5.1

0.9

0.03

2121

8441

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2030

7932

1.89

142.14

3.2

2.7

g/l

3.6

0.33

1929

7574

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1156

3669

2.31

139.86

1.1

121.3

116.8

4.43

1037

3334

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2254

9173

1.82

138.80

4.9

5.0

1.7

1.46

2134

8614

(3044290) Cell count panel - Cerebral spinal fluid

1439

5021

2.11

138.32

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1846

7105

1.91

135.16

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1215

3998

2.23

135.08

1.3

1.2

u/ml

4.1

4.0

0.06

386

1436

(40760888) Immunoglobulin light chains.free panel - Serum

1399

4874

2.11

134.97

3.0

3.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

1847

7136

1.91

133.68

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1827

7037

1.91

133.45

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2399

10063

1.76

133.42

5.1

3.8

48.9

48.1

0.81

2376

9947

(40768443) Skin Pathology biopsy report

2446

10370

1.74

131.05

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2323

9758

1.76

128.45

2.3

1.9

—

(3047181) Lactate [Moles/volume] in Blood

1803

7036

1.89

126.50

5.3

5.9

mmol/l

1.3

0.27

1611

6224

(3039162) Centromere protein B Ab [Units/volume] in Serum

927

2798

2.42

125.32

1.3

1.2

u/ml

42.3

58.3

1.13

167

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1577

5902

1.96

125.17

3.3

3.2

mmol/l

24.8

24.5

1.57

1411

5201

(3024263) Appearance of Synovial fluid

445

890

3.64

123.33

1.8

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1344

4774

2.07

123.17

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2201

9212

1.76

123.12

1.6

1.7

—

(3010421) pH of Blood

1667

6401

1.92

122.74

4.7

3.8

7.4

0.66

1459

5434

(3000330) Specific gravity of Urine by Test strip

2643

11658

1.68

122.44

4.0

3.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

1904

7687

1.82

119.99

4.4

4.1

mmol/l

1.3

1.4

3.06

1866

7550

(3017143) Hepatitis C virus Ab [Presence] in Serum

6253

33374

1.41

119.75

1.7

1.6

—

(1616796) Gas panel - Central venous blood

1477

5500

1.97

118.87

4.1

3.5

—

(40767503) Oxygen content in Capillary blood by calculation

1399

5117

2.01

118.39

2.8

2.5

16.4

16.6

0.75

745

2632

(3049717) Cytology report of Urine Cyto stain

2005

8279

1.78

117.30

2.4

2.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2116

8905

1.75

116.01

2.1

1.8

—

(3012501) Base excess in Blood by calculation

1484

5583

1.95

115.95

4.7

3.9

mmol/l

2.5

0.04

1042

3670

(3013290) Carbon dioxide [Partial pressure] in Blood

1484

5585

1.95

115.83

4.7

3.9

kpa

5.1

5.0

2.48

1456

5433

(3027315) Oxygen [Partial pressure] in Blood

1490

5616

1.95

115.79

4.7

3.9

kpa

8.6

8.7

1.34

1462

5463

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

651

1714

2.77

115.59

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

650

1710

2.77

115.59

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

650

1712

2.77

115.34

1.2

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2500

11037

1.67

115.24

4.4

3.3

mmol/l

25.4

25.2

3.08

2436

10694

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

646

1701

2.77

114.69

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

644

1701

2.76

113.68

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

643

1697

2.76

113.67

1.2

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2796

12748

1.62

113.61

3.0

2.6

e6/l

0.3

1.06

2717

12383

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1828

7426

1.81

112.80

1.6

iu/ml

6.5

4.5

0.18

415

1525

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

872

2715

2.35

110.11

1.2

1.1

96.2

95.1

0.51

805

2550

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6282

33995

1.39

110.07

1.9

1.7

1.5

1.4

23.78

5436

30296

(3002256) Pathology report gross observation

6198

33489

1.39

109.55

1.3

—

(3022313) Gas panel - Capillary blood

2391

10597

1.67

108.43

4.4

4.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2150

9290

1.71

107.16

4.5

4.2

mmol/l

24.8

24.7

0.81

2001

8625

(3023420) DNA double strand Ab [Units/volume] in Serum

813

2483

2.39

107.13

1.6

iu/ml

30.5

36.1

0.47

122

(3037756) Immunofixation for Serum or Plasma

1210

4361

2.03

106.55

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1016

3429

2.17

106.09

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1209

4371

2.03

105.55

1.3

1.2

titre

93.0

123.3

0.42

(3028271) Lactate [Moles/volume] in Capillary blood

1087

3790

2.10

104.51

2.1

1.8

mmol/l

1.7

1.8

3.47

1070

3697

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1566

6222

1.85

103.66

2.0

mg/l

11.1

10.8

0.45

1456

5836

(3020891) Body temperature

2056

8884

1.70

102.38

5.6

4.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

633

1752

2.63

102.24

1.2

1.1

u/ml

71.2

73.9

—

(21494755) Public health laboratory ask at order entry panel

2986

31730

0.66

99.13

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

788

2459

2.34

99.00

1.1

au/ml

70.9

58.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

798

2517

2.31

97.86

1.1

au/ml

46.8

21.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

408

909

3.26

96.35

1.5

5.6

4.2

0.60

220

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1617

6636

1.79

96.30

1.2

—

(3017732) Neutrophils [#/volume] in Blood

3463

17184

1.49

96.13

3.0

2.7

e9/l

4.2

4.1

0.60

2655

13548

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1752

7371

1.75

95.86

2.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2679

12580

1.57

95.78

1.1

titre

102.3

197.4

2.37

366

(4268621)

811

2603

2.27

95.55

2.5

2.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

1609

6610

1.79

95.48

4.7

4.4

mmol/l

3.9

1.03

1515

6184

(3028626) Oxygen [Partial pressure] in Capillary blood

1520

6149

1.81

94.89

3.7

4.0

kpa

8.4

8.5

0.96

1432

5750

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

990

3484

2.08

92.88

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1305

5066

1.89

92.75

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1057

3814

2.03

92.74

1.5

1.6

g/l

0.7

0.8

1.97

817

2858

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2900

13966

1.53

92.59

1.1

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1310

5116

1.88

91.41

3.1

2.7

umol/l

34.0

34.1

0.04

1119

4318

(3022806) Fractional oxyhemoglobin in Capillary blood

904

3094

2.13

91.13

2.0

1.8

89.9

89.8

0.23

890

3042

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

659

1976

2.43

90.39

1.2

1.1

mg/l

36.1

44.4

4.03

557

1622

(3021901) Oxygen saturation in Capillary blood

1165

4394

1.94

90.22

3.1

2.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1393

5572

1.83

90.15

2.3

2.2

g/l

129.7

130.8

0.83

1041

4101

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1387

5543

1.83

90.02

1.7

1.6

—

(3023410) Appearance of Cerebral spinal fluid

768

2476

2.26

89.55

1.8

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1251

4857

1.89

88.86

1.4

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

778

2535

2.24

88.48

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

907

3158

2.10

87.50

1.2

1.3

nmol/l

0.3

0.2

0.32

184

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

712

2252

2.31

86.79

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3675

18833

1.45

86.16

1.2

iu/ml

131.4

146.7

1.15

1247

7188

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1685

7225

1.71

86.07

1.4

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

904

3170

2.08

85.61

1.2

1.3

nmol/l

1.7

1.0

0.29

874

3054

(40761536) Microorganisms panel - Urine sediment

4341

22952

1.41

85.56

5.1

3.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

632

1908

2.41

85.44

1.1

mg/l

250.8

261.9

0.47

553

1665

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1617

6925

1.71

82.93

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1302

5239

1.82

82.63

3.7

2.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4526

24370

1.38

79.72

3.6

4.2

ug/l

13.8

28.0

3.77

3572

19457

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

448

1185

2.75

79.00

1.1

nmol/l

3.5

6.7

0.83

247

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1234

4955

1.82

78.83

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

605

1858

2.37

78.82

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

823

2877

2.09

78.59

1.2

1.3

—

(4027681)

531

1543

2.51

77.86

1.2

1.3

—

(3039000) Anion gap in Blood

1216

4887

1.82

77.46

6.1

7.1

mmol/l

11.1

11.3

1.39

1113

4399

(3018572) Chloride [Moles/volume] in Blood

1216

4888

1.82

77.41

6.1

7.1

mmol/l

104.7

105.3

4.17

1113

4401

(3004716) Salmonella sp identified in Stool by Organism specific culture

2819

14003

1.48

77.24

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

412

1058

2.83

76.72

1.1

iu/ml

4.0

4.2

0.10

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1302

5378

1.77

75.73

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

1562

6799

1.68

75.40

1.2

1.3

titre

97.6

129.8

1.34

143

633

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

402

1034

2.83

74.65

2.4

2.1

umol/l

117.5

146.0

1.15

223

502

(3016018) Differential panel - Cerebral spinal fluid

769

2676

2.10

74.32

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

628

2014

2.27

74.19

3.6

3.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

780

2732

2.08

74.11

1.2

1.3

nmol/l

—

(3034770) Mitochondria Ab [Titer] in Serum

1529

6656

1.68

73.77

1.2

1.3

titre

825.0

926.1

0.23

190

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

366

908

2.93

72.48

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

705

2418

2.13

70.74

1.2

u/l

61.7

68.2

0.94

492

1629

(3024139) IgG subclass 3 [Mass/volume] in Serum

699

2391

2.13

70.62

1.4

1.3

g/l

0.4

0.16

512

1638

(3027135) IgG subclass 1 [Mass/volume] in Serum

699

2397

2.13

70.17

1.4

1.3

g/l

6.4

7.0

3.57

512

1639

(4062490)

699

2398

2.12

70.09

1.4

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

698

2394

2.12

70.04

1.4

1.3

g/l

2.8

3.0

1.61

513

1639

(3037121) Protein [Mass/volume] in Urine

1802

8292

1.59

69.79

3.1

3.4

g/l

0.3

0.62

767

3959

(3003181) Sodium [Moles/volume] in Urine

992

3880

1.87

68.85

1.4

mmol/l

61.5

63.5

0.77

806

3033

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1083

4358

1.82

68.69

3.7

3.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

787

2864

2.00

67.48

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

770

2795

2.01

66.49

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3944

21361

1.37

66.29

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

452

1318

2.49

65.88

1.1

u/l

1.1

0.25

190

597

(3005988) Vibrio sp identified in Specimen by Organism specific culture

759

2758

2.01

65.36

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1490

6651

1.64

65.24

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

758

2755

2.01

65.23

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

766

2802

1.99

64.76

1.5

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

312

754

3.01

64.70

2.4

2.1

ug/l

68.1

62.1

0.54

307

735

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1001

4005

1.82

64.68

1.8

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1204

5093

1.73

64.45

6.4

6.0

iu/ml

5375.5

1054.1

0.61

174

747

(3038026) Centromere Ab [Units/volume] in Serum

515

1615

2.32

64.12

1.3

1.2

u/ml

62.5

45.5

0.31

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

997

3999

1.82

63.91

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

240

496

3.51

63.70

1.3

1.2

g/l

39.8

40.1

0.10

146

271

(3025468) Yersinia sp identified in Specimen by Organism specific culture

754

2760

1.99

63.62

1.5

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1803

19456

0.66

62.88

1.5

—

(3023419) Bacteria identified in Sputum by Culture

729

2648

2.01

62.85

2.4

2.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

475

1456

2.37

62.25

1.5

u/ml

24.7

24.2

0.06

297

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5093

28905

1.31

62.01

8.3

6.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

500

1581

2.30

61.11

1.3

1.2

u/ml

51.2

41.1

0.35

118

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

498

1577

2.30

60.67

1.2

u/ml

80.8

57.6

0.96

(3013166) Neutrophils/100 leukocytes in Synovial fluid

241

517

3.38

60.54

1.4

59.6

53.5

1.58

208

447

(3026389) Candida sp identified in Specimen by Organism specific culture

890

3519

1.84

59.74

1.4

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

451

1379

2.38

59.45

1.2

—

(4198724)

426

1281

2.42

58.25

2.3

2.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

523

1724

2.21

57.99

2.9

2.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

478

1519

2.29

57.79

1.2

u/ml

3.6

12.0

1.99

112

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

642

2299

2.03

57.59

1.5

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

211

430

3.56

57.21

1.3

39.6

39.4

0.03

144

292

(3017315) Amylase [Enzymatic activity/volume] in Urine

395

1161

2.47

56.71

1.2

u/l

199.3

307.0

2.25

369

1089

(21494890) Protein electrophoresis panel - 24 hour Urine

607

2160

2.05

55.40

2.0

2.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

468

1512

2.25

54.47

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

786

3078

1.86

54.40

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

468

1519

2.24

53.89

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

569

2004

2.07

53.40

1.2

titre

174.2

186.6

0.14

343

(21491868) Cryoglobulin [Mass/volume] in Serum

292

760

2.79

53.24

1.3

1.2

g/l

1.1

0.5

0.60

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

430

1356

2.30

52.96

1.2

u/l

90.7

94.8

0.35

372

1191

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

310

836

2.69

52.90

1.3

1.2

g/l

0.3

3.13

248

664

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

893

3672

1.77

52.76

1.1

—

(3044927) Protein electrophoresis panel - Urine

550

1922

2.08

52.70

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

840

3393

1.80

52.67

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

566

2000

2.06

52.67

1.2

titre

71.4

197.2

2.13

(3051611) Lipemic interference index of Serum or Plasma

681

2572

1.93

52.60

3.8

3.4

—

(3011985) Renin [Units/volume] in Plasma

802

3198

1.83

52.44

1.5

1.6

mu/l

65.4

64.0

0.07

713

2877

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

419

1317

2.31

52.00

1.2

u/l

28.0

24.6

0.57

360

1136

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

927

3888

1.74

51.16

3.3

3.1

u/ml

6800.9

6780.9

0.00

227

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

289

777

2.70

49.64

1.3

1.2

113.2

109.9

1.17

260

701

(3009466) Valproate [Moles/volume] in Serum or Plasma

922

3897

1.72

49.53

5.2

umol/l

354.1

373.4

3.23

793

3418

(3004809) Band form neutrophils/100 leukocytes in Blood

895

3754

1.74

49.40

3.1

3.3

1.2

1.5

1.83

666

2920

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2946

28047

0.74

49.19

1.6

1.7

—

(4094501)

1319

6128

1.57

48.94

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

386

1204

2.33

48.78

2.5

1.7

150.4

141.1

1.24

368

1134

(3048929) Epstein Barr virus Ab [Presence] in Serum

1848

9235

1.47

48.68

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1480

7066

1.53

48.64

5.1

4.2

mg/l

1.7

1.5

14.50

1362

6545

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

776

3138

1.80

48.51

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

740

2956

1.82

48.14

1.4

—

(3002619) Bacteria identified in Specimen by Culture

192

414

3.36

47.98

1.4

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

790

3224

1.78

47.91

1.7

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

741

2970

1.82

47.69

1.3

1.4

pmol/l

308.4

304.4

0.10

561

2330

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

343

1025

2.43

47.64

2.3

2.1

ug/min

96.6

105.2

0.09

236

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

388

1227

2.30

47.54

1.3

1.2

titre

39.4

93.4

2.09

101

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

405

1315

2.24

46.67

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

395

1269

2.26

46.67

1.3

1.2

titre

393.3

374.3

0.05

(3047007) Chlamydophila sp Ab [Presence] in Serum

871

3685

1.72

46.65

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

583

2180

1.95

46.42

3.1

3.3

59.6

58.8

0.31

365

1371

(3020191) Ethanol [Moles/volume] in Serum or Plasma

552

2028

1.98

46.23

1.8

1.4

promille

1.5

1.3

1.70

407

1552

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

518

1878

2.01

45.04

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

518

1878

2.01

45.04

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

518

1878

2.01

45.04

1.6

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1801

9097

1.45

44.84

1.4

—

(4034850)

1570

7731

1.48

44.52

10.0

9.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4922

28915

1.26

44.51

4.7

4.1

31.9

32.2

1.34

3595

19938

(3036071) Salmonella sp Ab [Titer] in Serum

265

724

2.66

44.21

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1518

7437

1.49

44.14

1.1

u/ml

4.6

5.5

0.29

148

1084

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

272

754

2.62

44.11

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

666

2647

1.83

44.08

2.3

1.9

mg/l

21.7

28.2

2.29

174

685

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

834

3546

1.71

43.90

1.3

u/l

33.4

35.6

0.19

739

3065

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

486

1745

2.02

43.41

1.3

u/ml

1.4

1.2

0.12

220

710

(3045424) Erythrocytes [Presence] in Urine

928

4081

1.66

43.09

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1349

6481

1.52

43.07

1.8

1.9

iu/l

3.8

21.7

1.27

425

2462

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

288

837

2.50

42.49

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

402

1355

2.15

42.36

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

364

1178

2.24

42.33

1.2

u/ml

15.6

10.3

0.20

114

(3008037) Lactate [Moles/volume] in Venous blood

1109

5120

1.58

42.29

4.2

3.0

mmol/l

1.5

1.6

3.60

1085

5021

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

176

390

3.27

42.24

1.3

1.2

mg/l

61.5

48.2

0.15

135

286

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

227

587

2.80

42.01

1.1

—

(44806118)

650

2603

1.82

42.01

1.6

—

(44790049)

650

2603

1.82

42.01

1.6

—

(44790047)

650

2604

1.82

41.95

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

407

1384

2.14

41.95

1.4

—

(44790048)

650

2605

1.82

41.90

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

447

1582

2.05

41.54

1.1

1.2

ratio

1.1

0.80

166

593

(3051651) Icteric interference index of Serum or Plasma

439

1544

2.07

41.48

4.1

3.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1185

12819

0.66

41.38

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

506

1876

1.96

41.36

2.0

g/24h

0.9

1.0

0.16

106

(3009015) Lactate [Moles/volume] in Synovial fluid

100

146

4.96

41.33

1.3

1.2

mmol/l

6.1

6.7

0.35

(3027456) Digoxin [Moles/volume] in Serum or Plasma

915

4065

1.64

40.85

3.3

3.1

nmol/l

0.8

0.30

703

3149

(3017817) Protein [Mass] in Urine collected for unspecified duration

530

2009

1.92

40.62

2.4

2.6

0.1

0.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2533

13789

1.35

40.50

2.9

3.2

u/ml

58.5

49.5

0.29

2423

13338

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1927

19017

0.72

40.37

1.4

—

(3011288) Drugs identified in Urine by Screen method

1689

8598

1.44

40.31

4.5

2.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

376

1268

2.15

39.61

1.4

1.6

ug/l

8.4

8.0

0.10

344

1140

(4035726)

3829

22126

1.27

39.50

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

659

2708

1.77

39.13

1.7

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

910

4084

1.62

39.04

1.1

au/ml

19.6

10.8

1.20

277

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1165

5548

1.53

38.75

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

547

2129

1.87

38.73

2.9

2.6

—

(3042631) Mycobacterium sp identified in Specimen

713

3007

1.73

38.69

2.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2636

14537

1.33

38.58

1.4

1.3

iu/l

27.6

26.2

1.27

2243

12451

(3026470) Cobalt [Mass/volume] in Blood

349

1155

2.19

38.53

2.0

ug/l

4.1

3.6

0.37

300

1013

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

668

2772

1.75

38.37

1.2

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

214

564

2.75

38.30

1.1

mg/g

7.1

6.4

0.55

203

543

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

499

1894

1.91

38.13

1.3

mmol/l

2.0

2.1

1.50

458

1760

(4024509)

528

2044

1.88

38.02

1.6

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

289

889

2.36

37.82

2.5

1.7

167.6

166.2

0.08

271

839

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1104

5226

1.54

37.75

1.3

u/ml

271.4

258.4

0.70

723

3350

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

446

1639

1.98

37.44

2.2

2.3

99.4

97.2

0.68

417

1536

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

377

1305

2.10

37.20

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

633

2614

1.76

36.99

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

179

436

2.98

36.89

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

179

436

2.98

36.89

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

179

436

2.98

36.89

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

179

436

2.98

36.89

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

303

963

2.28

36.84

2.8

2.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

828

3688

1.63

36.63

1.7

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

335

1115

2.18

36.50

1.1

98.3

96.3

0.51

265

893

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

487

1864

1.90

36.32

1.1

1.3

u/ml

—

49.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1250

6130

1.49

36.18

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

858

3871

1.61

36.06

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

606

2494

1.77

35.85

3.6

3.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5201

31441

1.22

35.56

1.7

1.8

—

(3025577) Chromium [Mass/volume] in Blood

334

1125

2.15

35.36

2.1

2.0

ug/l

2.5

2.3

0.48

272

941

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

173

424

2.96

35.30

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

1023

4835

1.54

35.25

4.4

3.0

mmol/l

7.4

7.6

1.18

1001

4758

(1001926) Buprenorphine [Presence] in Urine by Screen method

1859

9852

1.38

35.19

3.2

2.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1149

5573

1.50

35.10

1.5

1.4

u/ml

17.9

19.4

0.11

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1155

5612

1.50

34.98

1.6

1.5

—

(3045716) Anion gap in Serum or Plasma

301

978

2.23

34.79

2.7

2.3

mmol/l

8.7

9.3

1.97

213

721

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1049

5004

1.53

34.65

2.7

2.0

nmol/l

0.9

0.8

2.06

870

4241

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

591

2439

1.76

34.65

1.6

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

234

682

2.49

34.44

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1631

8494

1.40

34.25

3.0

3.6

u/ml

4426.8

1272.8

0.39

1361

7316

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

393

1428

2.00

34.11

1.7

1.5

u/l

7.9

5.8

1.11

213

686

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

206

567

2.63

34.02

1.3

nmol/l

123.4

125.3

0.06

150

426

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

270

848

2.31

33.79

1.2

1.1

89.8

90.5

0.09

125

392

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

937

10203

0.66

33.74

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1009

10823

0.67

33.70

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

230

672

2.48

33.69

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

937

10196

0.66

33.63

1.5

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

282

905

2.26

33.58

1.1

ng/l

288.2

550.4

0.75

223

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

932

10142

0.66

33.46

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

332

1144

2.11

33.22

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

332

1145

2.10

33.15

1.5

1.6

—

(3008295) Osmolality of Serum or Plasma

559

2301

1.77

33.09

1.5

mosm/kgh2o

281.9

279.5

1.52

413

1816

(3047352) Trisomy 18 risk [Likelihood] in Fetus

732

8364

0.63

33.00

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7510

47241

1.18

33.00

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

754

8558

0.63

32.99

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

940

10171

0.66

32.80

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

327

1126

2.11

32.78

2.1

2.3

umol/l

27.9

43.3

0.70

118

(3005033) Fetal Nuchal fold Thickness US

734

8352

0.63

32.49

1.5

1.4

—

(3019977) pH of Arterial blood

349

1237

2.05

32.44

2.4

2.5

7.4

0.39

114

424

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

527

2148

1.78

32.27

1.9

2.5

nmol/l

18.9

19.8

1.40

489

2045

(3000093) Morphology [Interpretation] in Blood Narrative

549

2270

1.76

32.02

1.2

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

274

887

2.24

32.00

1.2

1.1

111.4

106.6

1.10

250

805

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1069

5209

1.50

31.96

1.6

1.5

u/ml

114.2

111.2

0.23

231

1107

(3003694) ABO and Rh group [Type] in Blood

12372

80957

1.14

31.80

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

901

4240

1.55

31.69

1.5

1.3

u/l

24.5

24.6

0.03

722

3546

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

672

2948

1.66

31.62

2.0

2.2

32.4

32.7

0.87

663

2927

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

270

874

2.24

31.55

1.1

88.3

90.4

0.47

123

403

(46235355) HIV 1 and 2 tests - Meaningful Use set

9250

59329

1.16

31.51

2.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

539

2228

1.76

31.48

1.6

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

300

1015

2.14

31.48

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

300

1016

2.14

31.40

1.4

—

(3017704) Immunofixation for Urine

322

1123

2.08

31.26

1.5

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1700

9056

1.37

31.16

2.0

1.7

—

(3034426) Prothrombin time (PT)

265

857

2.24

31.04

1.2

—

(3042517) Benzodiazepines panel - Urine

134

313

3.10

29.73

3.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

314

1109

2.05

29.52

1.1

iu/ml

200.5

215.7

0.18

314

1102

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

806

8791

0.66

29.27

1.8

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

628

2765

1.65

29.18

1.1

iu/ml

2.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

636

2813

1.64

29.03

3.0

2.3

—

(3004451) EKG impression Narrative

295

1027

2.08

28.83

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

281

963

2.12

28.60

2.5

2.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

394

1526

1.87

28.48

2.5

3.6

nmol/l

116.7

137.6

0.64

387

1496

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

305

1082

2.04

28.37

1.5

1.7

nmol/l

3.3

10.7

0.77

249

911

(1761482) Bacteria [#/volume] in Urine by Culture

1210

6184

1.43

28.30

5.6

3.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5691

35407

1.18

28.06

2.1

2.0

—

(3014271) Vancomycin [Susceptibility]

305

1091

2.03

27.75

3.3

2.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

884

4282

1.50

27.26

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

899

4370

1.50

27.26

1.1

—

(1002224) Polysomnography panel

1981

11036

1.31

26.87

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

319

1175

1.97

26.78

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

319

1175

1.97

26.78

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

319

1175

1.97

26.78

1.7

1.9

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.51

26.73

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1053

5303

1.45

26.69

1.8

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

188

560

2.43

26.57

1.4

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

328

1224

1.94

26.54

1.6

1.5

umol/l

20.7

25.2

2.12

318

1170

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

248

834

2.16

26.52

2.9

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

455

1885

1.75

26.47

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

312

1149

1.97

26.22

37.5

36.1

ug/l

7.3

0.06

289

1036

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

317

1175

1.96

26.16

1.7

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7665

49070

1.15

26.13

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2375

13598

1.28

26.13

2.5

2.3

u/l

6368.1

6053.9

0.17

817

5592

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

658

7309

0.65

26.11

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

156

428

2.64

26.07

1.1

umol/24h

0.7

0.8

0.34

209

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

440

1821

1.75

25.70

1.4

umol/l

12.6

12.1

0.77

421

1730

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

168

482

2.53

25.70

1.4

1.6

ug/l

0.4

0.42

114

311

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

227

751

2.19

25.30

1.2

1.3

25.6

21.1

0.36

125

(3000034) Microalbumin [Mass/volume] in Urine

481

2052

1.70

25.25

2.9

3.0

mg/l

56.3

48.6

0.21

346

1469

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

428

1767

1.76

25.23

1.7

1.9

mg/l

3.5

3.8

0.84

412

1678

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

484

2069

1.70

25.22

1.4

1.3

nmol/l

1.5

1.4

1.22

440

1881

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1088

5573

1.42

25.17

2.4

ug/min

128.1

106.6

0.73

605

3343

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

932

9602

0.70

25.09

1.5

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3215

19142

1.23

25.08

2.5

2.1

nmol/l

11.5

12.1

2.89

2815

16987

(3027923) C peptide [Moles/volume] in Serum or Plasma

322

1222

1.91

24.84

1.5

1.6

nmol/l

1.1

1.3

2.31

241

976

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

246

847

2.11

24.83

1.2

1.1

—

(21494434) Karyotype in Bone marrow

456

1926

1.72

24.82

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

289

1057

1.98

24.80

5.4

4.8

mg/l

2743.8

2423.5

0.08

216

773

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

402

1639

1.78

24.73

1.1

iu/ml

10.6

7.7

1.02

423

(3036603) Volume of Urine

400

1629

1.78

24.70

1.7

1.6

1875.4

1962.3

0.33

353

(3017569) Oxygen content in Arterial blood

272

978

2.02

24.48

2.0

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6213

39344

1.16

24.34

2.2

2.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

440

1852

1.72

24.26

1.6

1.5

—

(3011412) CD3 cells [#/volume] in Blood

558

2506

1.62

24.07

2.5

e9/l

1.3

1.2

1.00

336

1519

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

281

1029

1.98

24.05

3.7

3.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

119

295

2.92

23.99

1.8

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1594

8757

1.33

23.89

1.4

u/l

11.2

9.5

4.69

1293

7125

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

431

1812

1.73

23.88

2.6

e6/l

530.1

547.8

0.23

360

1485

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

234

804

2.11

23.77

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

318

1221

1.89

23.71

1.2

1.3

61.6

63.2

0.10

147

(43055442) Apixaban [Mass/volume] in Serum or Plasma

107

251

3.09

23.69

1.7

1.6

ug/l

97.7

113.6

0.86

208

(3010375) cycloSPORINE [Mass/volume] in Blood

304

1152

1.91

23.58

30.2

28.2

ug/l

115.7

120.7

0.55

246

967

(3016038) Potassium [Moles/volume] in Urine

378

1538

1.78

23.45

1.3

mmol/l

34.0

34.1

0.02

313

1335

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1172

6161

1.39

23.36

1.3

1.2

—

(4146454)

519

2311

1.63

23.19

2.8

2.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

393

4775

0.59

23.03

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

389

1605

1.76

23.03

2.1

2.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

408

1713

1.73

22.74

1.7

1.5

umol/l

64.9

73.4

1.75

125

(3012565) Volume of 24 hour Urine

318

1239

1.86

22.70

2.2

1862.4

1997.5

1.45

277

1114

(3001964) Herpes simplex virus Ag [Presence] in Specimen

217

738

2.13

22.65

1.7

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

415

1753

1.72

22.64

2.6

2.7

e9/l

0.2

0.09

357

1482

(3003434) Protein [Mass/volume] in Pleural fluid

635

2986

1.54

22.56

1.6

1.4

g/l

32.4

33.3

1.10

569

2674

(3038177) Helicobacter pylori Ab [Presence] in Serum

881

4434

1.44

22.48

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

608

2837

1.56

22.36

5.3

9.4

mmol/l

7.4

7.3

0.06

510

2320

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

572

2635

1.58

22.25

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

477

2106

1.64

22.07

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

185

596

2.25

22.05

1.3

109.4

105.6

0.72

177

558

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

716

3478

1.50

21.89

1.5

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

577

2675

1.57

21.85

1.5

1.4

e6/l

2519.6

3002.1

0.44

405

1922

(3028308) Erythrocytes [#/volume] in Pleural fluid

532

2422

1.59

21.76

1.5

1.4

e6/l

56096.1

51857.0

0.11

310

1442

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

272

1022

1.93

21.69

2.1

2.3

ug/l

64.9

205.1

0.71

260

964

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

687

3315

1.51

21.69

1.1

g/l

1.5

0.49

612

3022

(3016879) Cocaine [Presence] in Urine

2068

11912

1.27

21.64

3.1

2.1

—

(3047189) Immunofixation for 24 hour Urine

258

954

1.96

21.55

2.0

1.8

—

(3020491) Glucose [Moles/volume] in Blood

433

1880

1.67

21.39

1.8

mmol/l

7.1

6.6

2.56

329

1398

(40768446) Kidney Pathology biopsy report

267

1003

1.93

21.32

1.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

177

568

2.26

21.31

1.3

1.1

75.5

75.6

0.00

138

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

274

1039

1.91

21.28

1.9

2.0

umol/l

29.4

28.3

1.07

266

1005

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

167

523

2.31

21.27

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

177

570

2.25

21.14

1.3

1.1

87.8

88.7

0.06

144

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

202

687

2.13

21.13

2.4

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

202

687

2.13

21.13

2.4

2.5

—

(3012441) Differential panel - Pleural fluid

510

2317

1.60

21.06

1.6

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

289

1120

1.87

21.02

1.4

1.6

mmol/24h

4.8

5.1

0.20

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

331

1340

1.79

20.95

1.7

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1977

11379

1.27

20.82

1.7

1.6

mu/l

313.5

315.9

0.09

1795

10223

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

218

770

2.05

20.69

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

303

1199

1.83

20.66

1.2

1.1

u/l

21.1

24.8

0.62

227

918

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

234

850

2.00

20.58

1.4

pmol/l

15.3

14.7

0.32

197

721

(3045142) Bone marrow Pathology biopsy report

549

2553

1.56

20.55

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

164

3.44

20.54

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

473

2124

1.62

20.51

1.3

mmol/l

6.6

6.2

1.60

442

1959

(3034988) Calcium [Moles/volume] in Capillary blood

139

407

2.47

20.51

1.7

2.6

mmol/l

1.2

1.90

133

386

(3016244) Insulin [Units/volume] in Serum or Plasma

411

1782

1.67

20.43

3.3

mu/l

27.2

26.1

0.22

388

1675

(44813793)

417

1817

1.67

20.35

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

144

431

2.42

20.29

1.6

1.3

—

(3045788) Cell count panel - Pleural fluid

462

2070

1.62

20.22

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

301

1198

1.82

20.16

1.2

1.1

u/l

80.7

85.9

0.41

241

952

(3000764) Benzodiazepines [Presence] in Urine

2192

12851

1.24

19.69

3.1

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

237

880

1.95

19.62

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

425

1880

1.64

19.59

2.3

2.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

416

1832

1.65

19.51

1.1

mg/l

302.4

290.5

1.89

367

1665

(3028300) Cannabinoids [Presence] in Urine

2206

12955

1.24

19.51

3.1

2.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

366

1559

1.70

19.46

3.0

2.8

ug/l

21.5

23.9

0.29

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

777

3932

1.44

19.33

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

11397

75994

1.11

19.30

4.9

4.7

ug/l

3.0

3.5

0.93

10210

68216

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

123

350

2.54

19.27

1.4

nmol/l

71586.8

263866.7

0.95

285

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

172

570

2.19

19.24

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

273

1072

1.85

19.12

2.5

umol/l

56.7

53.7

0.89

219

908

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

148

462

2.32

19.05

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

281

1116

1.83

18.99

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

376

1627

1.68

18.88

1.5

1.4

u/l

13.0

12.6

0.48

355

1575

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

445

2011

1.61

18.85

1.4

1.3

u/l

406.5

489.4

0.72

415

1904

(3027008) Opiates [Presence] in Urine

2195

12934

1.24

18.82

3.0

2.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

391

1714

1.65

18.70

12.1

12.5

mmol/l

0.6

0.45

352

1572

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

134

405

2.40

18.54

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

373

1619

1.67

18.53

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

124

364

2.47

18.26

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

247

2.81

18.25

1.4

titre

64.0

156.3

—

(3007463) Buprenorphine [Presence] in Urine

4.11

18.16

9.5

7.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

173

590

2.12

18.06

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

529

2515

1.53

18.00

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

337

1438

1.70

17.86

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

240

925

1.88

17.85

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

173

593

2.11

17.84

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

171

586

2.11

17.65

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1773

10277

1.26

17.62

2.2

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

887

4672

1.38

17.58

2.8

3.5

u/ml

607.3

834.6

0.29

799

4245

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

163

550

2.15

17.50

1.1

—

(3019174) dRVVT (LA screen)

217

2.90

17.49

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

565

2742

1.50

17.47

2.9

3.4

nmol/l

4.9

8.4

0.97

546

2668

(3006245) CD3-CD19+ cells/100 cells in Blood

269

1085

1.80

17.34

2.6

2.3

9.8

11.4

1.24

252

1020

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

107

300

2.58

17.33

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

307

1289

1.73

17.26

1.6

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

833

4356

1.39

17.26

1.6

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

125

379

2.39

17.21

1.2

1.4

titre

12.9

232.7

2.23

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

953

5104

1.36

17.04

2.0

1.8

pmol/l

179.8

192.8

3.28

891

4867

(3027944) Amphetamines [Presence] in Urine

2142

12734

1.23

16.90

2.9

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

396

1793

1.60

16.71

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

440

2043

1.56

16.69

2.3

2.1

74.4

72.1

2.65

419

1972

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

372

1660

1.63

16.66

2.0

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

303

1281

1.71

16.65

1.6

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

170

596

2.07

16.58

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

256

1032

1.80

16.56

1.8

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

410

1885

1.58

16.25

2.5

2.6

e6/l

813.0

727.1

0.55

163

708

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

259

1055

1.78

16.20

2.5

2.2

28.2

29.0

0.40

246

1007

(3013005) Retinol [Moles/volume] in Serum or Plasma

270

1116

1.75

16.08

2.0

umol/l

2.0

1.9

0.42

254

1061

(3006270) Folate [Moles/volume] in Blood

426

1981

1.56

16.08

1.2

1.1

nmol/l

359.4

374.7

0.78

343

1676

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

431

2013

1.55

15.96

2.3

2.1

13.3

13.6

0.15

241

984

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

442

2080

1.54

15.83

1.9

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

251

1021

1.78

15.79

8.4

10.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

252

2.64

15.64

1.3

1.2

—

(3000012) Reticulocyte production index

300

1289

1.69

15.58

1.4

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

228

2.73

15.55

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

160

563

2.06

15.49

1.4

umol/l

17.3

17.1

0.27

143

504

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

221

871

1.84

15.42

2.9

3.0

umol/l

28.8

0.01

166

659

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

678

3495

1.41

15.33

2.3

2.8

u/ml

1840.6

573.3

0.43

645

3307

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1643

9614

1.24

15.06

1.3

miu/ml

216.8

226.2

0.48

712

4582

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

229

921

1.80

14.99

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

229

921

1.80

14.99

1.9

2.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

123

396

2.25

14.87

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

128

421

2.20

14.72

1.9

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

209

823

1.84

14.66

6.7

6.4

mmol/l

25.1

24.9

0.33

196

742

(3037556) Urate [Mass/volume] in Serum or Plasma

164

595

2.00

14.65

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

240

2.62

14.62

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

127

419

2.19

14.50

1.3

1.6

—

(3042733) HLA Ab [Presence] in Serum

224

905

1.79

14.47

5.0

—

(44806071)

104

315

2.39

14.44

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

229

934

1.78

14.34

1.9

2.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

161

586

1.99

14.27

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

779

4162

1.36

14.23

1.1

iu/ml

12189.8

866.1

0.45

182

943

(3000060) B lymphocytes [#/volume] in Blood

212

848

1.81

14.16

2.7

2.2

e6/l

397.7

890.9

0.72

128

457

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

257

2.53

14.15

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

181

691

1.90

13.99

2.1

1.6

—

(3035880) pH of Pleural fluid

276

1196

1.67

13.95

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4327

35199

0.88

13.94

1.7

—

(3036048) Francisella tularensis Ab [Titer] in Serum

147

524

2.03

13.81

1.1

1.2

titre

285.7

557.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

107

338

2.29

13.57

1.5

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

761

4083

1.35

13.56

4.1

3.6

u/ml

29.5

40.3

1.06

729

3937

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

132

456

2.10

13.48

5.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

169

639

1.92

13.46

1.6

ug/l

9.4

9.2

0.17

169

639

(40768806) Pleura Pathology biopsy report

477

2363

1.46

13.45

1.6

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

169

2.87

13.32

1.8

umol/l

51.4

43.7

0.92

169

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

252

2.50

13.31

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

107

341

2.27

13.31

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

750

4036

1.35

13.12

1.1

u/ml

2.5

2.9

0.52

279

2061

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

232

2779

0.60

13.09

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

358

1681

1.54

13.06

1.8

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

461

2292

1.46

12.79

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

107

350

2.21

12.55

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

218

916

1.72

12.40

1.9

2.8

ug/l

1.1

1.2

0.05

203

872

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

144

532

1.96

12.32

1.2

pmol/l

255.9

331.6

1.43

102

404

(40757373) Influenza virus identified in Isolate

130

463

2.03

12.30

1.8

1.6

—

(3025315) Body weight

198

2.63

12.25

5.2

4.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.82

12.24

1.6

nmol/l

277.6

243.9

0.10

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

338

1595

1.54

12.10

1.3

u/l

11.9

14.4

1.89

313

1480

(3008536) Aspergillus sp Ab [Presence] in Serum

129

464

2.01

11.91

1.8

2.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

505

5069

0.72

11.88

1.4

1.3

ug/l

3.2

3.7

1.01

434

4599

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

227

2.49

11.87

2.1

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

705

3820

1.34

11.84

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

232

2.46

11.81

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

296

1365

1.57

11.75

1.4

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

446

2243

1.44

11.70

4.0

3.6

u/ml

41.0

51.0

0.76

439

2217

(3014148) Varicella zoster virus Ab [Titer] in Serum

701

3805

1.34

11.65

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

275

1249

1.60

11.65

1.7

1.6

iu/ml

2654934.8

1825914.4

0.27

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

221

2.49

11.60

1.3

1.2

mg/l

53.1

46.6

0.42

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

347

1664

1.51

11.56

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

251

1118

1.63

11.51

1.1

u/ml

9.3

10.7

0.19

202

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

107

364

2.13

11.45

1.1

—

(3036180) Methadone [Presence] in Urine

4.82

11.44

2.4

2.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

226

983

1.67

11.38

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

265

1205

1.59

11.19

1.1

miu/ml

1626.1

1480.9

1.22

265

1205

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

213

2.48

11.09

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

720

3956

1.32

11.03

1.9

2.1

titre

2.3

7.0

1.75

119

(21494815) CD4 cells/100 lymphocytes in Specimen

459

2349

1.42

10.98

2.4

2.2

42.6

41.4

0.20

276

(3006922) Hepatitis E virus Ab [Presence] in Serum

373

1836

1.47

10.98

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

129

479

1.95

10.94

1.3

1.4

mu/l

76.5

81.7

0.08

366

(40762365) Oxygen content in Arterial blood by calculation

112

397

2.04

10.80

3.1

2.8

ml/dl

15.0

14.6

0.69

103

365

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1292

7647

1.23

10.76

1.8

1.6

nmol/l

40.7

42.1

1.02

1262

7483

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

360

1767

1.48

10.76

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

473

4712

0.72

10.67

1.5

1.6

—

(3028433) Virus identified in Specimen by Culture

194

825

1.70

10.65

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

104

361

2.09

10.61

1.2

1.1

u/ml

0.4

0.2

0.32

214

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

113

405

2.02

10.59

2.7

2.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1028

5949

1.25

10.53

1.1

u/ml

1.5

1.9

0.80

444

2463

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

233

2.36

10.42

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

128

483

1.92

10.39

5.2

6.2

68.9

71.0

0.42

108

375

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

119

441

1.95

10.18

2.9

2.4

mmol/l

7.1

7.5

0.57

260

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

302

1447

1.51

10.18

2.5

2.9

43.4

38.3

2.68

473

(3010503) CD19 cells [#/volume] in Blood

309

1489

1.50

10.14

2.4

2.6

e9/l

0.2

0.4

0.66

301

1450

(40762814) Titanium [Mass/volume] in Blood

315

2.14

10.12

2.2

2.3

ug/l

3.4

3.8

0.45

109

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8928

60377

1.09

10.11

4.3

4.0

22.1

22.0

0.28

3992

28509

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

455

2364

1.40

10.04

3.8

5.0

u/ml

128.9

103.3

0.34

127

771

(3005082) Progesterone [Moles/volume] in Serum or Plasma

169

2039

0.60

9.96

1.3

1.4

nmol/l

29.2

32.1

0.71

148

1885

(3037692) Legionella sp identified in Specimen by Organism specific culture

187

809

1.67

9.69

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

154

631

1.77

9.68

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

339

1700

1.45

9.16

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

271

2.16

9.13

2.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

340

1707

1.44

9.13

1.1

—

(40768793) Breast Pathology biopsy report

990

5805

1.24

9.08

1.3

—

(3024471) HLA-A [Type]

203

914

1.61

9.04

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

169

2.48

8.92

1.3

1.2

ug/l

93.7

112.2

0.51

104

(3011897) Casein IgE Ab [Units/volume] in Serum

128

512

1.81

8.77

1.2

1.3

u/ml

32.8

5.0

0.82

120

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

120

2.77

8.76

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

106

399

1.92

8.75

1.3

1.5

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.50

8.73

1.7

1.6

nmol/l

234.5

300.7

0.18

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

211

2.30

8.73

1.1

umol/24h

1.8

1.7

0.50

211

(3004775) Volume in Urine collected for unspecified duration

362

1855

1.41

8.72

2.3

684.4

675.5

0.14

238

1264

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

194

872

1.61

8.72

2.1

mg/l

8.8

9.5

0.91

155

699

(4211845)

267

1292

1.50

8.67

3.8

2.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

144

599

1.74

8.66

1.1

u/ml

2.3

2.7

—

(3024932) HLA-DR beta [Type]

198

897

1.60

8.63

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

151

2.54

8.55

3.4

2.9

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

122

2.73

8.51

1.5

1.7

0.7

0.5

0.30

105

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

139

2.60

8.46

1.6

1.4

9.6

13.6

1.07

102

(3001729) Color of Synovial fluid

144

2.56

8.38

1.4

1.6

—

(1761868) Lipid panel - Serum or Plasma

13298

100622

0.94

8.36

3.0

2.6

—

(4015189)

131

536

1.77

8.35

2.4

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

104

396

1.90

8.32

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

191

866

1.60

8.31

1.9

1.7

u/ml

11858.1

10405.0

0.05

106

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

162

2.46

8.30

1.5

1.4

42.9

37.4

0.39

114

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

609

1.71

8.20

1.3

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

168

743

1.64

8.10

2.7

3.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

151

2.49

8.09

2.1

1.9

ug/g

166.1

175.3

0.17

130

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1049

6267

1.22

8.09

1.4

pmol/l

128.3

125.0

0.06

1017

6111

(3003888) Timothy IgE Ab [Units/volume] in Serum

907

5343

1.23

8.03

1.1

u/ml

5.9

5.6

0.14

481

2795

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

276

1368

1.46

8.00

1.7

1.8

u/field

1.3

2.6

4.73

202

986

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

161

2.43

7.96

1.3

1.4

—

(3006462) Nitrate [Presence] in Urine

244

1182

1.50

7.93

3.9

2.7

—

(3048879) Bone marrow aspiration report

146

626

1.69

7.92

1.7

1.9

—

(3023383) Lactate [Moles/volume] in Pleural fluid

150

649

1.67

7.88

1.4

1.3

mmol/l

3.1

3.6

0.91

141

590

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

147

633

1.68

7.86

1.3

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

231

2.16

7.83

2.2

2.1

umol/l

1.3

0.04

212

(3020123) Porphyrins [Interpretation] in Serum or Plasma

137

2.53

7.75

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

237

2.14

7.74

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

315

1.98

7.73

1.5

1.3

48.0

53.6

0.50

159

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

376

1.89

7.70

5.2

5.1

ug/min

52.4

45.3

0.43

294

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

380

2011

1.37

7.64

2.1

2.0

u/field

1.7

2.3

1.11

175

862

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

117

2.66

7.62

1.5

1.3

1.7

1.3

0.20

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

328

1.94

7.54

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

225

1086

1.50

7.47

1.1

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

591

3343

1.28

7.47

1.6

1.8

titre

1722.7

4150.8

1.59

148

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.49

7.46

1.0

—

(3016750) Collection duration of Urine

272

1364

1.44

7.46

2.3

2.2

min

507.0

500.3

0.49

187

1015

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

167

2.34

7.39

2.4

2.7

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

223

2.14

7.35

3.8

4.6

mg/l

2.3

2.0

0.52

186

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

276

1395

1.43

7.27

1.0

ng/l

35.5

42.8

2.24

193

974

(3013466) aPTT in Blood by Coagulation assay

155

2.38

7.26

1.1

36.3

37.4

0.33

132

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

274

1384

1.43

7.24

1.0

ng/l

266.7

348.8

2.15

194

987

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

220

2.14

7.22

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

275

1393

1.43

7.16

1.0

ng/l

805.2

730.0

1.79

189

957

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

117

486

1.74

7.16

2.5

2.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

231

1133

1.48

7.12

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

116

482

1.74

7.09

1.3

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

109

2.65

7.09

1.1

1.2

u/ml

13.9

19.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2843

18504

1.12

7.08

1.9

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.89

7.04

1.6

1.4

u/l

0.4

0.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

395

1.81

6.94

1.5

1.3

ng/l

82.5

324.2

0.57

248

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.70

6.90

1.4

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

519

2919

1.29

6.90

1.9

2.0

ug/l

24.4

25.4

0.11

506

2857

(3017461) Flecainide [Moles/volume] in Serum or Plasma

120

2.53

6.81

1.5

1.9

umol/l

0.6

0.7

0.44

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

154

698

1.60

6.81

1.9

1.8

au/ml

97.8

127.4

0.40

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

147

2.36

6.75

1.1

1.0

u/l

9.3

9.2

0.02

147

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

246

2.03

6.74

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

855

5104

1.22

6.73

1.1

u/ml

1.2

1.1

0.13

378

2231

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

198

2.16

6.72

1.4

1.2

nmol/l

13.0

16.2

1.09

(3001019) Free T4 and TSH panel - Serum or Plasma

1965

16042

0.88

6.69

1.7

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

342

1821

1.36

6.68

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

364

1.83

6.65

2.3

2.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.79

6.65

1.1

1.0

u/ml

0.1

0.2

0.08

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.89

6.64

1.2

1.1

u/l

633.6

366.0

0.28

(3012494) Peanut IgE Ab [Units/volume] in Serum

181

859

1.53

6.57

1.1

u/ml

1.7

20.7

1.01

111

513

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

200

2.13

6.57

1.3

pmol/l

11.8

12.7

0.13

168

(44806420)

143

643

1.61

6.55

2.2

2.4

—

(3018133) Calcium [Moles/volume] in Urine

108

453

1.73

6.44

2.2

2.3

mmol/l

2.8

2.6

0.27

411

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

105

437

1.74

6.43

2.8

2.6

mg/l

71.9

48.4

0.30

(3020618) Glucose [Moles/volume] in Synovial fluid

3.07

6.42

1.1

1.0

mmol/l

4.7

5.7

0.87

(3003129) Base excess in Capillary blood by calculation

122

530

1.67

6.41

1.8

1.6

mmol/l

1.5

0.2

3.11

114

498

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.93

6.38

1.0

u/ml

0.0

0.1

0.77

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

369

1.80

6.38

1.4

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

111

471

1.71

6.36

1.2

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

213

2.07

6.32

1.3

ml/s/173m2

1.3

1.7

0.57

138

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

319

1.86

6.27

2.7

2.6

mmol/l

0.9

1.5

2.69

233

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

121

528

1.66

6.26

1.1

1.2

u/ml

0.8

8.7

3.02

389

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

130

2.39

6.24

1.2

1.1

u/l

197.7

61.2

0.42

102

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

362

1.80

6.20

1.1

pmol/l

3.2

7.8

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

112

481

1.69

6.16

1.3

1.6

nmol/l

0.2

0.11

351

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

3.39

6.15

10.2

9.0

44.2

46.3

0.10

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

333

1.83

6.07

3.0

3.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

115

500

1.66

6.05

1.4

25.4

22.3

0.53

408

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

120

528

1.64

6.03

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

308

1643

1.36

6.01

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

3.00

6.00

1.0

u/ml

0.2

0.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

214

2.03

5.90

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

656

0.47

5.80

2.8

3.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

172

2.15

5.80

1.0

u/ml

0.1

1.4

1.10

135

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

655

0.47

5.78

5.6

6.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

141

2.26

5.65

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

256

1340

1.38

5.64

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6453

43993

1.07

5.63

3.0

2.9

ug/l

0.7

0.8

7.68

4443

28143

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

541

3143

1.25

5.60

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

259

1.90

5.59

1.4

1.3

u/l

660.0

192.0

0.43

186

(3021661) Pineapple IgE Ab [Units/volume] in Serum

4.13

5.55

1.1

1.0

u/ml

0.0

0.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

746

4486

1.21

5.54

2.0

2.3

umol/l

6.9

7.0

0.04

563

3265

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

133

615

1.57

5.50

2.0

1.9

u/l

53.9

39.0

0.33

118

550

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

564

1.59

5.50

1.1

—

(3025130) Human papilloma virus identified in Specimen

701

4195

1.21

5.48

1.7

—

(40768441) Liver Pathology biopsy report

340

1873

1.31

5.39

1.5

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

268

1.86

5.37

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

126

581

1.57

5.30

1.5

1.4

g/l

14.0

13.5

0.25

445

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

161

785

1.48

5.25

1.5

1.4

61.7

62.5

0.10

126

648

(3041918) Cholesterol [Moles/volume] in Pleural fluid

395

1.69

5.14

1.4

1.2

mmol/l

1.6

1.7

0.31

240

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

124

2.28

5.13

3.9

3.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.86

5.11

1.1

3.3

2.7

0.22

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

294

1.80

5.09

1.0

1.1

u/ml

0.2

1.9

0.80

160

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.89

5.05

9.7

8.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

113

517

1.58

4.94

1.5

1.3

g/l

26.2

40.2

0.64

404

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

209

1.94

4.93

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

150

2.12

4.93

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

340

1.72

4.93

1.6

1.3

—

(3012898) Urea [Moles/volume] in Urine

250

1.85

4.93

1.4

1.8

mmol/l

149.6

178.3

1.17

218

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

336

1874

1.30

4.91

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

261

1.83

4.89

1.0

1.1

u/ml

0.0

0.6

2.01

149

(3010726) Horse dander IgE Ab [Units/volume] in Serum

823

5059

1.18

4.84

1.1

u/ml

1.8

2.6

1.36

197

1305

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

206

1.93

4.80

1.1

1.3

—

(3033799) Differential panel - Peritoneal fluid

148

724

1.48

4.79

2.5

1.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

183

933

1.42

4.77

2.5

2.9

au/ml

132.3

146.1

0.14

128

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

157

2.07

4.77

1.1

u/field

1.2

1.1

0.24

106

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.56

4.75

1.1

1.0

u/ml

0.1

0.08

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

138

2.15

4.75

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

196

1013

1.40

4.74

3.1

3.5

mg/l

8.1

0.02

159

810

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

291

1.77

4.70

1.0

1.1

u/ml

0.0

0.9

1.60

163

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

567

3379

1.22

4.70

2.4

2.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

367

1.68

4.69

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

465

2716

1.24

4.67

1.3

1.4

mmol/l

12.1

11.6

0.44

148

585

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

650

3927

1.20

4.67

1.4

mmol/l

7.0

0.06

486

2764

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

324

1.72

4.67

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

159

2.05

4.62

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

261

1.80

4.61

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

135

654

1.49

4.60

1.6

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3491

23450

1.08

4.57

2.1

2.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

305

1.73

4.55

1.0

1.1

u/ml

0.4

5.2

2.20

242

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

117

2.23

4.55

10.6

9.7

e6/l

100.3

303.3

0.85

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4498

30513

1.07

4.53

1.5

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

284

1.76

4.52

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

212

1121

1.37

4.50

1.5

1.4

73.2

72.5

0.28

202

1067

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

307

1.72

4.45

1.1

u/ml

1.3

3.7

1.11

239

(3001893) Eosinophils/100 leukocytes in Pleural fluid

138

677

1.48

4.44

1.5

1.4

2.4

2.9

0.30

110

577

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

208

1100

1.37

4.42

1.5

1.4

mu/l

502.8

743.4

1.27

198

1046

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.73

4.40

1.0

g/l

0.2

0.11

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

310

1.70

4.31

2.3

3.3

umol/l

41.2

42.7

0.22

272

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

252

1.78

4.26

1.5

1.4

69.5

73.0

0.36

207

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

226

1.82

4.24

1.6

mg/l

1.9

0.01

142

(3009871) Measles virus Ab [Titer] in Serum

173

894

1.40

4.24

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

318

1.68

4.20

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

297

1.71

4.16

1.0

u/ml

0.0

0.2

2.23

184

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

4.82

4.12

2.3

1.3

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.76

4.12

1.0

1.1

g/l

0.5

0.0

—

(4212803)

208

1.84

4.09

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

114

2.16

4.03

34.9

8.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

389

1.60

4.03

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

137

1403

0.71

3.98

1.8

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

120

590

1.47

3.88

15.6

7.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

107

514

1.51

3.87

16.5

7.6

—

(3042628) Porphyrins [Moles/volume] in Urine

8.26

3.86

1.1

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

163

849

1.39

3.86

2.5

1.8

e6/l

1679.9

3856.8

0.69

104

579

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

153

790

1.40

3.81

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

325

1871

1.26

3.80

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

167

1.91

3.78

2.9

2.3

mmol/l

21.2

19.5

0.17

145

(3032352) Blasts [#/volume] in Cerebral spinal fluid

273

1.70

3.77

3.7

2.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

122

607

1.45

3.73

1.5

1.4

22.2

20.5

0.27

106

552

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.30

3.72

1.0

1.1

pmol/l

156.6

257.8

1.22

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

444

1.53

3.69

3.5

5.5

u/l

56.0

56.5

0.01

172

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

184

1.85

3.69

1.0

1.1

iu/ml

29.2

16.7

0.38

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.25

3.68

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

190

1.83

3.65

1.5

1.4

—

11.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

129

2.02

3.64

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

766

4801

1.16

3.63

1.4

1.5

nmol/l

0.4

0.97

578

3877

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

100

2.17

3.63

1.1

1.4

u/field

1.0

1.2

0.60

(3006969) Lambda light chains [Mass/volume] in Urine

2.69

3.59

1.0

1.1

g/l

0.0

0.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

3.0

2.0

0.51

142

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

2.8

2.7

0.06

146

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

3.7

2.0

1.06

153

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

1.2

1.1

0.08

131

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

3.8

2.6

0.58

154

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

3.1

3.4

0.18

131

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

2.1

1.7

0.37

152

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

1.5

0.9

0.64

145

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

223

1.75

3.58

1.6

mg/l

3.0

1.8

0.85

135

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

181

1.84

3.57

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.24

3.54

1.9

2.8

mmol/l

4.2

4.4

0.95

(3014891) Appearance of Pleural fluid

307

1.63

3.50

1.7

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

172

1.85

3.49

4.3

4.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

314

1.61

3.45

1.5

1.2

mmol/l

1.9

1.1

0.47

199

(3016228) CD19 cells/100 cells in Blood

187

1016

1.33

3.44

2.1

7.4

8.7

1.07

180

993

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

286

1646

1.26

3.40

1.5

1.3

umol/l

4.2

5.4

7.39

263

1521

(3036312) Salmon IgE Ab [Units/volume] in Serum

153

1.89

3.39

1.1

u/ml

0.5

2.2

1.42

105

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

133

1.96

3.37

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

148

1452

0.74

3.37

1.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

208

1.74

3.27

2.8

2.3

mg/l

3.0

3.2

0.22

201

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

101

2.08

3.19

14.0

7.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

259

1.65

3.19

3.3

2.7

mg/l

1.5

1.3

0.24

178

(36303858) Crystals [Presence] in Urine

2.98

3.15

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

479

1.47

3.15

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

268

1547

1.25

3.14

1.4

mmol/l

5.6

5.5

0.45

247

1466

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.12

3.14

1.3

1.2

g/l

0.1

0.09

(3011544) Albumin [Mass/volume] in Pleural fluid

211

1.71

3.13

1.1

g/l

17.0

17.1

0.03

197

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

102

2.06

3.12

1.1

u/field

1.0

1.3

0.46

(21494814) CD8 cells/100 lymphocytes in Specimen

181

995

1.32

3.11

2.1

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

150

803

1.35

3.09

1.7

1.8

—

(3007542) Rye IgE Ab [Units/volume] in Serum

138

1.89

3.07

1.0

1.1

u/ml

0.7

0.6

0.05

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

163

885

1.33

3.06

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

2.20

3.04

1.7

—

(40768795) Lymph node Pathology biopsy report

421

2558

1.19

3.01

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

142

759

1.35

2.97

2.5

1.7

e6/l

8037.5

12578.9

0.50

413

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

310

1.56

2.96

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

771

0.67

2.94

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.63

2.93

2.1

2.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

110

1.97

2.91

4.0

3.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

255

1.62

2.90

2.0

1.7

mg/l

1.6

1.7

0.26

213

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

216

1967

0.79

2.87

1.8

1.7

—

(3033942) Copper [Moles/time] in 24 hour Urine

116

1.93

2.85

1.1

1.3

umol/24h

0.3

1.1

1.56

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

4.82

2.81

1.0

—

(3044007) Cell count panel - Peritoneal fluid

128

680

1.36

2.80

2.4

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

224

1.65

2.79

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.44

2.79

4.4

4.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.46

2.75

1.3

1.4

e6/l

40.3

64.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

386

1.48

2.75

2.9

2.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

267

1569

1.23

2.73

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

209

1.66

2.73

1.1

1.0

u/ml

0.7

1.0

0.24

129

(3050794) Legionella sp Ab [Presence] in Serum

204

1.67

2.70

1.0

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

188

1.69

2.68

1.1

1.0

u/ml

0.2

0.4

0.64

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

145

1.80

2.68

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.23

2.63

1.1

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

141

1.80

2.61

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

115

1.89

2.60

4.1

3.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

136

1.81

2.59

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

163

1.73

2.58

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

281

1.54

2.56

3.1

—

(3017509) Phencyclidine [Presence] in Urine

351

1.48

2.56

2.2

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

335

1.49

2.51

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

332

2851

0.84

2.51

1.6

mmol/l

8.0

7.5

2.77

209

1674

(21494567) Legionella sp IgM Ab [Presence] in Serum

170

1.70

2.50

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

264

1566

1.22

2.50

5.7

6.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

1.74

2.49

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

165

1.71

2.48

1.6

1.3

umol/24h

374.3

310.4

0.66

165

(40763480) Human metapneumovirus Ag [Presence] in Specimen

117

1.85

2.48

1.7

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

257

1.55

2.40

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

154

864

1.29

2.38

1.0

u/ml

5.0

10.4

2.71

115

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

184

1.65

2.37

1.1

u/ml

28.3

31.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1479

9884

1.08

2.36

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

114

614

1.34

2.35

1.3

ug/l

79.6

307.7

1.97

322

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

185

1.64

2.33

1.0

1.1

u/ml

4.9

9.6

0.64

131

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

341

1.46

2.33

1.5

1.4

10.8

11.1

0.03

185

(3010370) Gastrin [Moles/volume] in Serum or Plasma

395

1.43

2.32

1.6

1.8

pmol/l

44.0

47.2

0.14

336

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.92

2.32

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

119

647

1.33

2.31

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

197

1144

1.25

2.31

1.9

2.0

—

(3017400) Magnesium [Moles/volume] in Urine

2.24

2.29

1.1

1.3

mmol/l

3.0

3.4

0.23

(3023430) Cat dander IgE Ab [Units/volume] in Serum

631

4047

1.13

2.29

1.1

u/ml

4.8

5.3

0.30

262

1721

(3046914) Granular casts [#/area] in Urine by Computer assisted method

2.36

2.26

1.5

1.3

u/field

0.7

0.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

202

1181

1.24

2.24

3.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

108

1034

0.75

2.22

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

138

1.73

2.22

1.0

1.1

u/l

2.6

3.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

101

1.86

2.21

1.2

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

2.89

2.18

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.93

2.18

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1399

9366

1.08

2.17

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

123

1.76

2.16

1.0

u/ml

0.1

0.7

1.42

(3007456) Orange IgE Ab [Units/volume] in Serum

2.16

2.12

1.1

1.0

u/ml

0.1

0.3

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

289

1.48

2.11

3.2

3.1

mg/l

22.1

22.7

0.14

272

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

164

1.63

2.04

1.5

1.3

pmol/l

16.9

18.8

0.29

133

(3019897) Erythrocyte distribution width [Ratio] by Automated count

496

4060

0.88

2.03

3.3

2.4

13.2

13.1

0.81

488

4006

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.02

2.03

1.1

mmol/l

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

536

1.34

2.02

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

536

1.34

2.02

1.3

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

214

1276

1.21

2.00

1.9

2.2

u/l

194.6

205.0

1.60

214

1264

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

149

1.65

1.97

4.3

5.3

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.03

1.96

1.0

u/ml

0.2

1.1

1.31

(40768800) Prostate Pathology biopsy report

587

4744

0.89

1.96

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

172

1.60

1.95

1.2

31.6

23.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

271

1.47

1.94

1.4

1.3

27.6

24.2

0.31

217

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

535

1.33

1.91

1.3

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

326

1.42

1.90

11.6

9.4

umol/l

0.3

0.4

0.70

300

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.05

1.90

1.5

1.7

ug/l

90.0

120.0

—

(3024316) Viscosity of Plasma

118

1.72

1.87

2.4

1.7

mpas

1.5

1.7

1.39

(3002079) Sodium [Moles/time] in 24 hour Urine

2.49

1.86

1.0

1.1

mmol/24h

139.0

146.8

0.17

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

135

0.43

1.85

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

269

1.45

1.82

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.58

1.81

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.58

1.81

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.58

1.81

1.1

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.58

1.81

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.58

1.81

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.58

1.81

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.58

1.81

2.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

170

1.57

1.80

1.7

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

306

1904

1.16

1.80

1.1

u/ml

7.9

2.4

0.60

121

580

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

142

1.63

1.79

1.4

1.7

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.62

1.79

1.2

1.0

umol/l

19.8

22.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

182

1.55

1.78

6.6

5.4

—

(3022725) Serotonin [Moles/volume] in Serum

1.88

1.78

1.5

nmol/l

629.0

1022.5

0.89

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.94

1.76

3.4

3.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.09

1.76

1.3

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

201

1.51

1.73

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.75

1.71

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.19

1.70

1.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

4.02

1.69

1.0

1.2

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.05

1.69

1.1

1.0

u/ml

0.1

0.6

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.34

1.67

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.34

1.67

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

106

1.71

1.66

1.5

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

154

911

1.22

1.63

1.2

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

170

1.53

1.59

1.0

1.1

u/ml

13.4

17.1

0.18

142

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.27

1.57

1.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.62

1.56

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

237

1.43

1.53

1.2

1.1

u/l

22.5

20.4

0.25

150

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.33

1.51

1.4

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

311

1.37

1.51

2.3

2.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.68

1.48

1.2

1.4

nmol/l

420.4

533.6

0.43

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.89

1.46

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

531

3479

1.10

1.45

1.0

1.1

u/ml

0.6

0.5

0.10

118

761

(3014133) Dog dander IgE Ab [Units/volume] in Serum

654

4329

1.09

1.44

1.1

u/ml

4.3

5.0

0.40

264

1754

(3013945) Hepatitis B virus e Ab [Presence] in Serum

163

1.51

1.43

1.8

1.4

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.07

1.40

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

101

1.65

1.39

1.6

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

141

845

1.21

1.36

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

142

1.53

1.35

1.5

1.1

—

(36304079) Mucus [Presence] in Urine sediment

3.01

1.33

1.0

1.1

—

(3025481) Topiramate [Mass/volume] in Serum or Plasma

3.01

1.33

1.2

2.7

mg/l

3.2

6.8

—

(3010937) Rubella virus Ab [Presence] in Serum

178

1.46

1.33

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

326

1.33

1.30

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

141

850

1.20

1.30

1.2

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.92

1.27

1.4

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.31

1.27

1.0

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

282

0.67

1.25

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.73

1.24

4.5

6.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

323

1.32

1.23

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.22

1.22

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

117

1.55

1.20

1.0

—

(3009992) Blasts/100 cells in Bone marrow

2.41

1.20

2.5

1.5

4.2

18.3

—

(3046861) Legionella sp Ag [Presence] in Urine

129

1.51

1.19

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

170

1052

1.17

1.19

2.5

2.4

nmol/l

139.3

154.6

1.18

146

922

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

218

1375

1.15

1.18

1.2

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.14

1.18

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

194

1215

1.16

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

578

1.23

1.15

1.2

1.3

—

(3007147) Virus identified in Stool by Electron microscopy

2.58

1.15

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

475

1.25

1.14

2.0

1.8

ug/l

9.8

2.8

0.49

296

(40758292) HTLV I+II Ab panel - Serum

456

1.25

1.13

1.4

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.70

1.11

1.1

u/field

1.9

1.3

0.50

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

400

1.27

1.10

1.0

ug/l

80.6

81.2

0.04

321

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

305

1.30

1.08

2.3

2.5

u/field

0.8

0.6

0.88

305

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

356

1.28

1.08

1.2

1.3

—

(3000285) Sodium [Moles/volume] in Blood

293

1.31

1.07

1.1

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.81

1.02

1.8

1.3

mmol/24h

2.1

2.3

0.17

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

215

1.35

0.99

1.0

u/ml

0.9

1.6

0.47

143

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.74

0.99

1.4

1.5

nmol/l

93.9

137.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

178

1.38

0.98

1.6

3.0

pmol/l

1.6

450.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

125

1058

0.85

0.98

3.1

3.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.90

0.98

4.1

3.8

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.90

0.98

1.5

1.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.63

0.98

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.81

0.94

1.0

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.51

0.91

1.8

2.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

1.93

0.89

1.0

1.1

78.4

83.4

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.68

0.89

4.5

5.6

mg/l

3.3

6.5

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.68

0.89

1.2

1.1

—

(4133840)

112

691

1.17

0.88

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

258

1.29

0.88

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

220

1.31

0.88

3.7

2.8

—

(3029612) Listeria sp Ab [Titer] in Serum

1.63

0.87

1.4

—

(4281824)

428

2863

1.08

0.86

1.2

1.1

—

(3003577) Lead [Moles/volume] in Blood

196

1.33

0.85

1.3

1.4

umol/l

0.1

0.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

156

0.65

0.83

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

378

1.22

0.81

7.6

7.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.52

0.81

1.0

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

232

1.28

0.76

7.4

2.5

20.4

7.9

2.59

(3007733) Chloride [Moles/volume] in Urine

1.59

0.75

1.0

1.7

mmol/l

104.9

84.2

0.70

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.72

0.75

1.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

2.13

0.75

1.6

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

189

1231

1.11

0.71

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

319

1.22

0.71

1.3

2.1

mmol/l

7.0

7.6

0.43

120

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.51

0.71

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1524

10642

1.04

0.70

1.7

1.6

mg/l

3.7

3.5

0.31

1166

7179

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

102

640

1.15

0.69

2.8

2.5

ng/l

85.0

111.3

1.24

346

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.49

0.67

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

179

1.29

0.66

2.5

2.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

123

1.35

0.64

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

553

0.85

0.62

1.5

1.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.61

0.61

1.1

—

(3020650) Glucose [Presence] in Urine

118

757

1.13

0.61

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

238

1861

0.92

0.57

1.2

1.3

g/l

1.4

1.5

0.11

(3006567) Chloride [Moles/time] in 24 hour Urine

1.57

0.57

1.3

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.67

0.57

1.8

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.55

0.55

1.6

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

199

0.76

0.55

1.1

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

102

1.35

0.54

5.2

2.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.45

0.53

1.1

1.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

212

1.23

0.53

2.7

2.2

65.0

55.7

0.82

136

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

198

1320

1.08

0.52

5.0

6.4

u/ml

665.6

3168.1

0.58

294

(3011325) HIV 1+2 Ab [Presence] in Serum

148

1.27

0.51

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.41

0.50

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.61

0.46

1.0

1.2

—

(40758358) Immune stain study

118

1.29

0.46

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.41

0.45

1.0

1.1

titre

1795.7

2200.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

344

1.16

0.45

2.9

2.7

pmol/l

56.4

76.4

0.96

299

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

1.29

0.45

1.1

1.0

8.4

9.1

0.49

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

1.29

0.45

1.1

1.0

36.5

35.7

0.44

101

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

1.29

0.45

1.1

1.0

21.4

0.01

100

(3014599) Egg white IgE Ab [Units/volume] in Serum

274

1867

1.06

0.43

1.1

u/ml

1.9

6.2

1.24

505

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.62

0.42

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.57

0.42

1.2

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.42

0.0

4.5

—

139.5

—

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

0.8

—

(3006598) pH of Arterial cord blood

237

0.82

0.41

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.51

0.41

1.2

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

345

0.86

0.40

1.2

mmol/l

20.7

20.3

0.24

287

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

195

1318

1.07

0.40

1.6

1.8

—

(3004959) Base excess in Arterial cord blood by calculation

235

0.83

0.38

1.0

mmol/l

-2.5

-2.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.30

0.38

1.2

1.1

nmol/l

252.6

262.3

0.09

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.30

0.37

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.27

0.35

1.0

u/ml

1.0

0.2

—

(40760409) HLA-A [Type] by High resolution

1.24

0.31

1.0

—

(40763590) HLA-DQ beta [Type]

1.24

0.31

1.0

—

(40760410) HLA-B [Type] by High resolution

1.24

0.31

1.0

—

(46236302) HLA-C [Type] by High resolution typing

100

1.23

0.29

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

227

0.86

0.29

1.0

1.1

—

(3049233) Organic acids panel - Urine

1.30

0.28

1.1

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.25

0.27

1.0

—

(3013862) HLA-DP [Type]

101

1.22

0.27

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

169

1.16

0.25

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.24

0.23

1.3

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

172

1.14

0.21

2.9

2.1

14.8

18.3

0.22

(3022475) Manganese [Moles/volume] in Blood

167

0.87

0.21

1.3

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.8

—

(3035060) Mercury [Moles/volume] in Blood

1.28

0.20

1.5

1.6

nmol/l

6.1

10.7

—

(3018291) Platelet Ab [Presence] in Serum

1.18

0.18

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.12

0.17

1.3

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

224

1.10

0.17

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.18

0.17

1.6

2.4

mu/l

4.8

2.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

663

4711

1.02

0.16

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

372

1.07

0.16

10.9

6.9

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.10

0.15

1.0

—

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

150

1.11

0.14

1.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

661

4708

1.02

0.14

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

258

0.92

0.13

1.0

mu/l

6.3

8.8

2.99

210

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

109

1.13

0.13

1.1

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.19

0.12

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

282

2083

0.98

0.12

1.3

pmol/l

158.7

112.4

0.22

120

643

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

323

0.94

0.12

9.4

7.1

—

(3022670) pH of Venous cord blood

1.13

0.10

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.06

0.09

3.4

2.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.06

0.09

2.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.06

0.09

1.4

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.06

0.09

1.4

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

284

2089

0.98

0.09

18.4

18.3

nmol/l

1515.6

2965.2

0.92

269

1999

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

474

1.04

0.08

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

272

1937

1.02

0.08

1.1

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.07

0.07

5.1

mmol/l

0.4

0.2

—

(3034614) HLA Ag [Interpretation]

1.02

0.07

1.1

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

441

1.03

0.06

4.7

5.8

—

(3013762) Body weight Measured

110

0.92

0.06

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

238

1706

1.01

0.03

1.0

u/ml

0.7

0.8

0.07

248

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

202

1.04

0.03

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

780

5625

1.00

0.02

4.5

3.1

mg/l

23.7

27.4

2.30

500

3571

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

272

1976

1.00

0.01

13.6

13.1

nmol/l

814.4

1341.9

0.53

264

1911

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

118

1.04

0.01

1.2

—

(3001556) Androgen free Index in Serum or Plasma

323

0.98

0.01

1.3

1.2

—

(4038314)

178

0.97

0.00

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

105

0.96

0.00

1.1

1.2

1.5

1.4

0.37

105

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

128

1.02

0.00

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

115

1.01

0.00

1.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

126

0.98

0.00

2.4

3.6

—

0.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.4

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3032641) Amino acids panel - Urine

0.94

0.00

1.0

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.96

0.00

1.0

1.1

nmol/24h

82.1

108.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.90

0.00

5.3

6.8

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.3

—

2.2

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.7

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

6.4

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

0.98

0.00

1.4

3.5

nmol/l

195.8

358.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_LIMBPAIN and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_LIMBPAIN	1.285 [1.17, 1.41]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.118

During the follow-up period (1.1.1998 — 31.12.2019), 25686 out of 158303 females with M13_LIMBPAIN died.

Males

Parameter	HR [95% CI]	p-value
M13_LIMBPAIN	1.549 [1.39, 1.72]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 18641 out of 104226 males with M13_LIMBPAIN died.

Mortality risk

Mortality risk for people of age

years, who have M13_LIMBPAIN.

N-year risk	Females	Males
1	0.117%	0.256%
5	0.698%	1.589%
10	1.61%	4.047%
15	3.296%	7.567%
20	5.751%	12.661%

Relationships between endpoints

↥

Index endpoint: M13_LIMBPAIN – Pain in limb

GWS hits: 11

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pain in limb

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints